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1. Introduction 
The precise control of the strength of synaptic connections between neurons is the 
basis of the ability of the nervous system to produce adaptive, behaviorally relevant 
output. One of the most widespread means for synaptic depression, the negative 
regulation of synaptic strength, is endocannabinoid signaling. The endocannabinoid 
system consists of retrograde lipid messengers, most importantly 2-arachydonoyl-
glycerol (2-AG) or anandamide, their respective synthetic and degradative enzymes, and 
cannabinoid receptors (Castillo et al. 2012). Activation of the CB1 cannabinoid receptor 
leads to decreased neurotransmitter release due to the G-protein-mediated inhibition of 
voltage-gated Ca
2+
 channels and molecular constituents of the vesicle release 
machinery, and thus, CB1 activity is an important regulator of network activity (Katona 
and Freund 2008). The endocannabinoid system regulates synaptic strength in a 
multitude of regions and cell types of the central nervous system (CNS) (Katona and 
Freund 2012), and its impaired function has been implicated in numerous severe 
pathological states, including epilepsy, neurodegenerative disorders and Fragile X 
mental retardation (Busquets-Garcia et al. 2013; Di Marzo et al. 2015; Katona and 
Freund 2008; Pacher et al. 2006; Soltesz et al. 2015). In each of the implicated 
pathologies, different sites of the brain circuits are involved, and thus the exact role of 
endocannabinoid signaling is also varied. Our general aim is to elucidate the molecular 
composition of endocannabinoid signaling at specific synapse populations. 
Understanding molecular differences between particular cell types is required for 
understanding physiological and pathophysiological processes, but, in the immensely 
complex brain circuit, this has been an unresolved challenge for neuroscience (Lichtman 
and Denk 2011; O'Rourke et al. 2012). Therefore, we aimed to develop a method based 
on Stochastic Optical Reconstruction Microscopy (STORM) to allow cell-specific 
nanoscale imaging. STORM is a single molecule localization super-resolution 
microscopy method, capable of multichannel, 3-dimensional imaging of 
immunostaining at 10 nm lateral resolution (Bates et al. 2007; Huang et al. 2008b; Rust 
et al. 2006). While STORM has been used successfully to map the distribution of 
synaptic proteins in brain sections (Dani et al. 2010), existing methods did not visualize 
the cellular and subcellular context of the molecular localization data, and thus, did not 
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facilitate the cell type-specific analysis of such images. We have applied this method to 
resolve a paradox in endocannabinoid signaling at hippocampal GABAergic inhibitory 
synapses. Both perisomatically- and dendritically-targeting interneurons express 
presynaptic CB1, but, for hitherto unknown reasons, synapses of the former cell type are 
more sensitive to cannabinoids and exhibit tonic endocannabinoid signaling, while 
synapses of the latter are less sensitive and don’t express tonic signaling (Lee et al. 
2010a; Lenkey et al. 2015). 
In this chapter, I will introduce the molecular background of endocannabinoid 
signaling, the anatomical organization of the hippocampus and the CA1 region, the 
specific features of cannabinoid receptor-expressing hippocampal interneurons, and the 
recent advances in super-resolution microscopy methods. 
1.1. Endocannabinoid signaling 
1.1.1. Discovery of the endocannabinoid system 
The Cannabis sativa plant has been used for medicinal and recreational purposes 
since ancient times. Its major psychoactive constituent, Δ9-tetrahydrocannabinol (THC), 
was identified as early as the 1960s, however, the mode of action of this substance has 
remained elusive (Gaoni and Mechoulam 1964; Mechoulam et al. 1970). The discovery 
of the brain’s endogenous cannabinoid system began with the identification of the 
molecular target of THC, CB1, a G-protein coupled receptor (GPCR) of the rhodopsin 
family, which was found to be expressed throughout the brain at high levels (Devane et 
al. 1988; Herkenham et al. 1991; Herkenham et al. 1990; Matsuda et al. 1990). Soon 
after, endogenous ligands of CB1 were also discovered, and, unlike most signaling 
molecules, endocannabinoids proved to be lipids (Devane et al. 1992; Mechoulam et al. 
1995; Sugiura et al. 1995). The identification of endocannabinoids as retrograde 
messengers inhibiting neurotransmitter release at synapses was regarded as one of the 
most important discoveries in synapse research, and led to the birth of an exciting field 
of study (Ohno-Shosaku et al. 2001; Sudhof and Malenka 2008; Wilson and Nicoll 
2001). Since then, various roles of the endocannabinoid system in the function of the 
central nervous system (CNS) have been uncovered, and it became evident that 
impairment of endocannabinoid signaling is involved in a plethora of brain disorders 
(Castillo et al. 2012; Katona and Freund 2012; Pacher et al. 2006). In the following 
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sections, I will briefly overview the molecular components of endocannabinoid 
signaling, and their role in controlling synapses. 
1.1.2. Enzymatic pathways of the endocannabinoid system 
The first endocannabinoid to be isolated from brain was N-
arachidonoylethanolamine, also known as anandamide (Devane et al. 1992). 
Anandamide levels in the brain are two orders of magnitude lower than the 
concentration of 2-arachidonoylglycerol (2-AG), the second endocannabinoid 
discovered three years later (Sugiura et al. 1995). Anandamide and 2-AG share 
structural similarities, but also express fundamental differences. While both molecules 
contain arachidonic acid as their polyunsaturated fatty acid moiety, they have different 
efficacy on CB1 (anandamide and 2-AG being partial and full agonists on CB1, 
respectively), and their biosynthesis and degradation are regulated by distinct enzymatic 
pathways (Ahn et al. 2008). Blocking the biodegradation of both anandamide and 2-AG 
together mimics and occludes the physiological effect of THC, while blocking the 
degradation of only one mimics only some aspects of the response (Alger and Kim 
2011). 
Originally, cannabinoid receptors were considered as the endogenous molecular 
targets of anandamide, and the role of anandamide in certain forms of CB1-mediated 
synaptic plasticity remains established (Ade and Lovinger 2007; Azad et al. 2003; Kim 
and Alger 2010; Lovinger 2007). However, after the emergence of decisive evidence for 
the involvement of 2-AG in numerous endocannabinoid-mediated paradigms (Tanimura 
et al. 2010), reports concentrate on effects through vanilloid receptors, making 
anandamide primarily an endovanilloid, not and endocannabinoid (Chávez et al. 2010; 
Grueter et al. 2010; Lee et al. 2015; van der Stelt et al. 2005). Anandamide is a member 
of the highly diverse family of N-acyl-ethanolamine molecules (NAEs) (Di Marzo et al. 
1994; Schmid et al. 2002; Ueda et al. 2013). In the canonical pathway, these are 
synthesized by an N-acyl-phosphatidylethanolamine (NAPE)-hydrolyzing 
phospholipase D enzyme (NAPE-PLD) in a calcium-dependent manner, and degraded 
by fatty acid amide hydrolase (FAAH) (Cravatt et al. 2001; Cravatt et al. 1996; 
Okamoto et al. 2004). Interestingly, in NAPE-PLD-deficient mice, anandamide levels 
remain largely unchanged, while the level of long chain unsaturated (oleoyl- and 
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palmitoyl-) NAEs is decreased (Leung et al. 2006; Okamoto et al. 2007). These findings 
highlight the presence of alternative enzymatic pathways for anandamide metabolism 
(Rahman et al. 2014). While biochemical evidence suggests multiple synthetic routes 
through glycerophospho- or phospho-NAPE intermediates catalyzed by α/β-hydrolase 
domain containing (ABHD)-4 and glycerophosphodiesterase-1, or NAPE-phospholipase 
C and phospholipase B, respectively, it is not clear how these pathways contribute to 
brain anandamide levels (Ahn et al. 2008).  
In situ hybridization against NAPE-PLD mRNA, and immunostaining against the 
enzyme revealed that NAPE-PLD is expressed in various populations of glutamatergic 
cells throughout the forebrain, with high levels in mossy fibers of granule cells of the 
dentate gyrus (Egertova et al. 2008; Nyilas et al. 2008). High-resolution immunogold 
labeling revealed that the enzyme is localized to intracellular membrane structures, 
resembling the cisternae of the smooth endoplasmic reticulum (Nyilas et al. 2008; 
Reguero et al. 2014). Presynaptic targeting of the enzyme can predict its role in 
anterograde signaling (Egertova et al. 2008), or in intracellular signaling within axons.  
Unlike the elusive enzymatic pathways for anandamide synthesis, solid evidence 
supports that the major degradative enzyme of NAEs in the CNS is FAAH, as knockout 
(KO) mice exhibit a great increase in endogenous anandamide levels (Cravatt et al. 
2001; Cravatt et al. 1996). Besides the degradation by FAAH, minor oxidative pathways 
catalyzed by cyclooxygenase (COX)-2, 15-lipoxygenase, and cytochrome p450 
oxidases have also been described (Maccarrone et al. 2010). Oxidation of anandamide 
by COX-2 leads to the generation of prostamide E-2, a molecule with neuroprotective 
effects. FAAH was found to be expressed postsynaptically targeted to the endoplasmic 
reticulum, in weak association with the plasma membrane (Egertova et al. 2008; Gulyas 
et al. 2004). In FAAH KO mice, the proliferation of neural progenitors is increased, 
suggesting the role of anandamide in this process (Aguado et al. 2005).  
The second major endocannabinoid, 2-AG, belongs to the family of 
monoacylglycerols. At least three distinct enzymes can produce 2-AG from its 
phosphatidylinositol bisphosphate precursor found in the lipophilic layer of the plasma 
membrane. The physiologically most relevant pathway is the two-step reaction 
catalyzed by phospholipase C (PLC) β and diacylglycerol lipase (DGL)-α, as indicated 
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by the abolishment of endocannabinoid-mediated synaptic plasticity in the brain of 
DGL-α KO mice (Bisogno et al. 2003; Gao et al. 2010; Jung et al. 2007; Tanimura et al. 
2010). The synthesis of 2-AG is promoted by the activation of metabotropic (Gq/11-
coupled) receptors and/or elevated intracellular calcium concentrations, leading to on-
demand production of 2-AG from the precursor pool (Alger and Kim 2011; Jung et al. 
2005). The receptors and enzymes required for 2-AG synthesis are precisely targeted to 
the perisynaptic nanodomain of synapses (termed the “perisynaptic machinery”), further 
indicating the direct connection between the site of production and site of effect (Katona 
and Freund 2008; Katona et al. 2006). However, this configuration does not explain 
every observation. It cannot be ruled out that multiple pools of 2-AG, or separate 
functional sites of DGL-α activity exist, due to some experiments showing different 
effects between chronic (genetic) or acute (pharmacological) blockade of synthesis, and 
between 2-AG release triggered by calcium or by metabotropic receptor activation 
(Edwards et al. 2006; Hashimotodani et al. 2005; Lerner and Kreitzer 2012; Zhang et al. 
2011). Moreover, it was shown that the same synapse can release either 2-AG or 
anandamide contingent on the mode of metabotropic receptor activation or on stimulus 
protocol (Puente et al. 2011; Ramikie et al. 2014). 
Alternative enzymatic pathways of 2-AG biosynthesis include DGLβ, which was 
shown to be important during development and immune response, but its physiological 
role in 2-AG production in the adult brain is not clear (Hsu et al. 2012; Williams et al. 
2003). Lastly, 2-AG can be synthesized via phospholipase A and lyso-PLC enzymes, 
but the contribution of this pathway to brain 2-AG levels is not known (Ueda et al. 
2013). 
 The degradation of 2-AG can occur via hydrolysis or oxygenation. Hydrolysis of 
2-AG can be catalyzed by multiple enzymes, with monoacylglycerol lipase (MGL) 
being the most important regulator of brain 2-AG levels (Dinh et al. 2002; Taschler et 
al. 2011). The same reaction can also be catalyzed by ABHD6, ABHD12 and FAAH 
(Ahn et al. 2008). MGL was found to be expressed presynaptically, strategically 
positioned to terminate 2-AG signaling on CB1 receptors, thus, MGL activity limits the 
duration of endocannabinoid signaling (Gulyas et al. 2004; Pan et al. 2011; 
Uchigashima et al. 2011). The oxidation of 2-AG, mediated by COX-2, leads to the 
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production of prostaglandin E2 glycerol ester, a substance which has complementary 
effect on synaptic transmission compared to 2-AG. Thus, this pathway constitutes a 
molecular switch on the influence of endocannabinoid signaling on network activity 
(Katona and Freund 2012).  
How lipophilic endocannabinoids can serve as messengers in the aqueous 
intracellular environment is a fundamental question of the field, however, lies outside 
the scope of this introduction. According to the general, albeit challenged view, 
endocannabinoids are not stored, but synthesized on demand, and degraded 
constitutively (Alger and Kim 2011; Min et al. 2010). Some interesting results suggest 
that, for anandamide at least, membrane channels and shuttle proteins regulate transport 
(Nicolussi and Gertsch 2015). 
 
1.1.3. Cannabinoid receptors 
The first studies identifying the receptor of psychoactive phytocannabinoids pinned 
down CB1 and CB2, G-protein coupled receptors of the rhodopsin family (Howlett et al. 
1990; Matsuda et al. 1990; Munro et al. 1993). In the next decades, several receptors 
from all of the branches of the family were shown to be activated by phyto-, synthetic, 
and endocannabinoids (Brown 2007). However, the major behavioral effects of 
cannabinoids, also called the tetrad assay (hypolocomotion, hypothermia, analgesia, 
catalepsy), as well as the regulation of synapses by endocannabinoids are mediated by 
CB1 (Kawamura et al. 2006; Wilson et al. 2001; Zimmer et al. 1999). Being one of the 
most abundant GPCRs in the brain, CB1 is present in diverse cell- and synapse 
populations, and its multiple roles in the development and function of the CNS has been 
reviewed extensively (Alger 2012; Busquets-Garcia et al. 2015; Kano et al. 2009; 
Katona and Freund 2012). The involvement of CB1 has been discovered in a number of 
disease conditions, such as epilepsy, addiction, mental- and neurodegenerative disorders 
(Di Marzo et al. 2015; Fattore 2015; Parsons and Hurd 2015; Soltesz et al. 2015; Volk 
and Lewis 2015). Presynaptic CB1 receptors were first described on the axon terminals 
of specific hippocampal interneurons, but CB1 expression is abundant throughout the 
brain, and presynaptic receptors are present on a number of cell types (Herkenham et al. 
1990; Katona et al. 2001; Katona et al. 1999; Katona et al. 2006; Kawamura et al. 2006; 
DOI:10.14753/SE.2017.1972
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Uchigashima et al. 2007). While the number of receptors on an axon terminal ranges 
from barely detectable to several hundred between different synapse populations, CB1-
mediated synaptic plasticity is a robust physiological phenomenon throughout the brain 
(Heifets and Castillo 2009; Katona et al. 2006; Nyiri et al. 2005). What factors regulate 
the levels of presynaptic CB1 receptors? How is the subcellular distribution of the 
receptor shaped, and how the abundance and positioning of receptors determine 
endocannabinoid-mediated signaling? Despite some emerging results, these questions 
remained largely elusive. 
While a low level of receptors is detectable in the somatodendritic compartment of 
neurons, and there are functional implications for the role of somatodendritic receptors, 
the axonal enrichment of CB1 is striking, especially in neurons expressing the receptor 
at high levels (Bacci et al. 2004; Bodor et al. 2005; Katona et al. 1999; Maroso et al. 
2016). What mechanisms ensure the accumulation of CB1 in axons and axon terminals? 
Synaptic proteins are often anchored to or trapped at nanodomains by specific 
scaffolding proteins in a highly organized manner (Choquet and Triller 2013; Südhof 
2012; Tang et al. 2016). Although a cannabinoid receptor interacting protein (CRIP 1a) 
has been described, neither this, nor other binding partners of CB1 were found to be 
required for axonal targeting of the receptor, or for phasic endocannabinoid signaling 
(Howlett et al. 2010; Niehaus et al. 2007; Smith et al. 2015). On the other hand, agonist-
induced and constitutive internalization of the receptors emerged as major factors 
regulating CB1 surface expression and distribution. Agonist application leads to rapid 
internalization of CB1, followed by recycling (Coutts et al. 2001; Hsieh et al. 1999). 
However, the affinity of CB1 for endocytosis appears to be different in the 
somatodendritic and axonal compartments, with augmented constitutive endocytosis in 
the somatodendritic membrane (Leterrier et al. 2006; McDonald et al. 2007). 
Interestingly, when CB1 was overexpressed in cultured neurons, the striking axonal 
targeting was preserved irrespectively of the type of the transfected neuron, suggesting 
the autonomous preferential trafficking of the receptor without the presence of cell type-
specific auxiliary molecules. In axon terminals, CB1 diffusion is somewhat confined to 
the area of the bouton, as opposed to the free diffusion in connecting axonal segments 
(Mikasova et al. 2008). Brief treatment with CB1 agonist resulted in desensitization of 
the receptors, coupled with exclusion from synaptic domains and decreased mobility, 
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which suggests the existence of some synapse- or axon terminal-specific interactions. In 
contrast, long-term exposure to agonists lead to loss of surface receptors in axons, 
accumulation of intracellular labeling, and transport to the cell body for degradation 
(Coutts et al. 2001; Thibault et al. 2013). Endocytosis is likely to happen in the boutons 
and not in the preterminal axonal segments, as also suggested by the higher relative 
density of receptors in the latter (Leterrier et al. 2006; Nyiri et al. 2005). Altogether, 
these observations suggest that CB1 can diffuse freely in presynaptic membranes, but 
can probably interact with axon terminal-specific proteins. 
An interesting property of CB1 is its tonic activity. The application of 
antagonists/inverse agonists of CB1 increases the release probability above baseline 
levels, uncovering presynaptic tonic endocannabinoid signaling (Losonczy et al. 2004; 
Neu et al. 2007). The existence of the CB1 tone has been partially attributed to ambient 
levels of endocannabinoids (Katona and Freund 2012), and recent discoveries have 
shown that the molecular background of tonic and phasic endocannabinoid signaling is 
different (Földy et al. 2013; Lee et al. 2015). In particular, transsynaptic complexes 
formed by presynaptic neurexin and postsynaptic neuroligin have been shown to 
specifically modulate tonic endocannabinoid signaling (Anderson et al. 2015; Földy et 
al. 2013). In neuroligin-3 KO mice, synaptic transmission is enhanced by abolished 
tonic, but not phasic endocannabinoid signaling (Földy et al. 2013). 
Apart from their function in regulating neuronal activity, the role of CB1 and 
endocannabinoid signaling in the development of the CNS is also pivotal, regulating the 
proliferation, differentiation, migration and axonal growth of neurons. But these aspects 
are outside the scope of this chapter, and are reviewed in abundance (Gaffuri et al. 
2012; Harkany et al. 2007; Harkany et al. 2008). 
Among non-CB1 cannabinoid receptors, CB2 has been studied the most extensively. 
CB2 is present on peripheral immune cells, and microglia and oligodendrocytes in the 
brain, and the therapeutic immune properties of cannabis are mediated through this 
close evolutionary relative of CB1 (Dhopeshwarkar and Mackie 2014). Recently, 
convincing evidences for its neuronal expression and function have emerged (Li and 
Kim 2016; Stempel et al. 2016). Long-chain NAEs are known to be the endogenous 
ligands of peroxisome proliferator-activated nuclear receptors (PPAR-α), which are able 
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to regulate the excitability of neurons, and are co-expressed with NAPE-PLD in 
hippocampal neurons (Fu et al. 2003; Melis et al. 2008; Rivera et al. 2014). However, 
lipid messengers liberated in axon terminals are highly unlikely to reach nuclear 
receptors. Recently deorphanized GPCRs, GPR55 and GPR119 are also activated by 
NAEs, and GPR18 binds N-arachydonoylglycine, but, to date, very little is known about 
their physiological role (Godlewski et al. 2009). Endocannabinoids were shown to act 
on a number of targets in the brain, such as NMDA and glycine receptors, various 
transient receptor potential channels, T-type calcium and two-pore-domain potassium 
channels, but it is not known if these interactions in fact occur during physiological 
processes (Katona and Freund 2012). 
1.1.4. Endocannabinoid-mediated synaptic plasticity 
Retrograde endocannabinoid signaling acting on presynaptic CB1 regulates 
neurotransmitter release in the majority of CNS synapses. In line with its widespread 
expression in various cell types, the downstream effectors of CB1 signaling exhibit 
fundamental variability. The first example of such regulation was the discovery of 
depolarization-induced suppression of inhibition (DSI), a decrease in the strength of 
GABAergic inhibitory synapses after second-long depolarization of pyramidal cells 
(Pitler and Alger 1992). The link between DSI and endocannabinoids was revealed a 
decade later, with the demonstration of presynaptic CB1 inhibiting voltage-gated 
calcium channels (VGCC) (Wilson et al. 2001; Wilson and Nicoll 2001). This inhibition 
occurs directly, via the βγ subunit of G proteins, and results in short-term synaptic 
plasticity not only in inhibitory synapses, but also excitatory synapses of the cortex and 
other brain areas (Castillo et al. 2012). Long-term effects of CB1 are based on separate 
mechanisms, mostly the inhibition of the vesicle release machinery (Rab3B and RIM1α) 
via the α subunit of Gi/o proteins. This signaling is indirect, and involves the 
downregulation of adenylate cyclase and protein kinase A (Chevaleyre et al. 2007). 
Coincidently with CB1 activation, presynaptic calcium influx and calcineurin activity 
are also necessary for the induction of long-term plasticity (Heifets et al. 2008). 
Importantly, blocking this second limb prevents LTD but leaves DSI intact, thus, 
molecular mechanisms of short- and long-term depression by CB1 are indeed different. 
At cerebellar synapses, the downstream effect of CB1 also involves the activation of G 
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protein-gated inwardly rectifying and other potassium channels, thus regulating the 
excitability of the presynaptic membrane (Daniel et al. 2004). 
Endocannabinoid-mediated long-term depression (LTD) of excitatory or inhibitory 
(i-LTD) synapses can be induced with multiple protocols, including low-frequency 
stimulation of inputs, pharmacological activation of postsynaptic metabotropic 
receptors, or paired pre- and postsynaptic discharges (spike timing-dependent plasticity) 
with specific delays (Castillo et al. 2012). A recent study suggested that the direction of 
spike timing-dependent endocannabinoid-mediated depression or potentiation depends 
on the temporal dynamics of CB1 activity (Cui et al. 2016). Endocannabinoid signaling 
does not always happen in a retrograde, homosynaptic manner. First, it is also an 
important player in neuron-glia interactions. In astrocytes, CB1-induced glutamate 
release occurs via Gq/11 mediated signaling and rise in astrocytic calcium concentrations 
(Min and Nevian 2012). The resulting increase in extrasynaptic glutamate concentration 
could induce LTD by activating presynaptic NMDA and metabotropic glutamate 
receptors. Second, in inhibitory synapses, 2-AG liberated by a neighboring 
glutamatergic synapse can induce heterosynaptic i-LTD (Chevaleyre and Castillo 2003). 
Finally, postsynaptic CB1 or CB2 can influence the somatodendritic excitability of 
neurons (Bacci et al. 2004; Maroso et al. 2016; Stempel et al. 2016). 
The role of endocannabinoid signaling has also been implied in metaplasticity (i.e. 
the plasticity of plasticity), and homeostatic plasticity. Metaplasticity has been described 
both as a potentiation of the magnitude of DSI after repetitive stimulation of Schaffer 
collaterals, or as an increased likelihood of LTP in the glutamatergic input synapses of a 
cell that undergone i-LTD at the GABAergic synapses (Chen et al. 2007; Chevaleyre 
and Castillo 2004; Edwards et al. 2008). The homeostatic regulation of GABAergic 
synaptic strength has been shown to occur via tonic endocannabinoid signaling 
mediated by ambient levels of anandamide (Kim and Alger 2010). 
While KO mice lacking CB1, DGL-α or MGL are viable, fine-tuning of synaptic 
strengths by endocannabinoids is important in several aspects. To conclude this chapter, 
I would like to highlight a few physiological and pathophysiological examples for the 
role of endocannabinoid signaling in brain function (Heifets and Castillo 2009). During 
sensory map formation, competition between inputs on neocortical principal cells 
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involves endocannabinoid-mediated LTD of the weakening inputs. Thus, CB1 is 
required for both the reorganization following sensory deprivation, and for normal 
developmental map formation (Crozier et al. 2007; Deshmukh et al. 2007). The role of 
CB1 in associative learning is underlined by the necessity of endocannabinoid signaling 
for the extinction of conditioned fear, which requires LTD in amygdala synapses, and 
the facilitation of fear extinction when endocannabinoid signaling is enhanced 
(Chhatwal et al. 2005; Lutz et al. 2015; Marsicano et al. 2002). In Parkinson’s disease, 
reduced endocannabinoid production in the striatal medium spiny neurons of the 
indirect pathway contributes to increased corticostriatral excitability, and thus is an 
important aspect of the pathomechanism and also a therapeutic target (Kreitzer and 
Malenka 2007; More and Choi 2015). Endocannabinoid control of glutamatergic and 
GABAergic synapses is crucial for the balance of excitation and inhibition, and 
therefore in the pathogenesis of epilepsy (Soltesz et al. 2015). Accordingly, 
downregulation of CB1 was described on excitatory, but not inhibitory synapses of 
human epileptic patients, and impaired endocannabinoid signaling in the lack of DGL-α 
leads to increased epileptogenesis in mice (Ludanyi et al. 2008; Sugaya et al. 2016). In a 
mouse model of Fragile X mental retardation, synaptic endocannabinoid signaling is 
reduced concurrent with a mismatch in the precise synaptic targeting of DGL-α at 
glutamatergic synapses. The change in localization manifested in mere 50 nm difference 
in the distance of DGL-α from synapses between healthy and impaired animals (Jung et 
al. 2012). 
Together, these examples show that endocannabinoid signaling regulates synaptic 
strength in a multitude of brain regions and cell types, with considerable variability in 
its molecular organization and function. Gaining insight into how the involved receptors 
and enzymes participate in signaling at specific synapse populations thus leads to deeper 
understanding of the healthy and diseased brain. 
1.2. Organization of the hippocampal circuit 
1.2.1. Anatomical organization of the hippocampal formation 
The hippocampal formation is a group of brain areas of archicortical developmental 
origin, formed in the medial wall of the telencephalic ventricle. It is part of the limbic 
system, and receives highly processed multimodal sensory input from a multitude of 
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brain regions, cortical and subcortical alike. It plays especially critical role in long-term 
memory storage and recall, as exemplified by the famous case of the patient H.M., who 
has developed severe memory impairment after surgical removal of the hippocampi 
(Squire 2009). Because the rodent hippocampus is one of the most widespread model 
systems of neuroscience, extensive literature is available to review its anatomy 
(Andersen 2007; van Strien et al. 2009). What differentiates the hippocampal formation 
from all other cortical brain areas is its unique organization of associational 
connections, resulting, in a simplified view, in unidirectional flow of information along 
its subregions, namely the dentate gyrus, the sensu stricto hippocampus, the subiculum, 
the pre- and parasubiculum and the entorhinal cortex. The hippocampus comprises three 
well-defined anatomical regions, the CA1, CA2 and CA3. While the name 
hippocampus, originating from the sea horse-like shape of this structure in the human 
brain, is commonly used to refer to the three regions together (and often including the 
dentate gyrus), the regions themselves are usually abbreviated CA, after Cornu 
ammonis, another historical name of the same formation. In rodents, the relative size of 
the hippocampus (especially the dorsal hippocampus) compared to the neocortex is 
especially large, due to its prominent role in spatial memory and navigation. 
Canonically, information flow through the hippocampus has been described as the 
trisynaptic circuit, in which superficial pyramidal cells of the entorhinal cortex innervate 
dentate granule cells through the perforant path, granule cells in turn innervate CA3 
pyramidal cells via the mossy fibers, those then project to CA1 pyramidal cells through 
the Schaffer collaterals, and finally CA1 pyramidal cells project to the subiculum and 
back to the entorhinal cortex. The organization of principal cell somata in a single layer, 
and the strict laminar organization of inputs are also distinctive features of the 
hippocampus. Apart from the unidirectional trisynaptic pathway described above, the 
structure of the circuit is more complex, and regions of the hippocampal formation are 
extensively interconnected with other brain regions. First of all, the perforant path of 
entorhinal pyramidal cells projects directly to the CA1, also known as the 
temporoammonic pathway. The dentate granule cells massively innervate local 
interneurons, more so than CA3 pyramidal cells, and give rise to commissural afferents. 
The network of CA3 is characterized by the dense recurrent interconnection of its 
pyramidal cells, and the Schaffer collaterals also give rise to contralateral projections. 
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The hippocampal formation receives important subcortical, mostly modulatory input 
from the septum, supramamillary nucleus, locus coeruleus, ventral tegmental area and 
raphe, and many of these connections is reciprocal. Apart from the entorhinal and 
subicular cortices, CA1 pyramidal cells also innervate the retrosplenial cortex, 
amygdala and septum. In this study, I focus on local interneurons of the CA1, therefore 
in the next section I provide a brief overview of the specificities of the CA1 network. 
1.2.2. Structure and connectivity in the CA1 
The principal cell type of the CA1 is the pyramidal cell, probably the most studied 
cell type in the brain. These neurons exhibit remarkably homogenous dendritic 
morphology, and in rodents are organized into a single lamina of up to five cell layers 
thickness. Although pyramidal cells of the CA1 were originally considered a 
homogenous population based on their morphological uniformity, recent evidence 
shows the existence of several distinct populations of pyramidal cells, segregated by 
sublaminar localization, connectivity, neurochemical features, and transcriptome 
(Cembrowski et al. 2016; Lee et al. 2014; Mizuseki et al. 2011; Zeisel et al. 2015). The 
deepest part of the CA1, which is actually situated dorsally, due to the “upside down” 
position of CA1 in the brain, is the alveus, white matter containing myelinated fibers of 
the temporoammonic pathway. The first layer, oriens, contains basal dendrites of the 
pyramidal cells, and is innervated by Schaffer collaterals from the CA3. The pyramidal 
layer contains pyramidal cell somata, while cell bodies of interneurons can be found in 
every layer. The radiatum contains apical dendrites of pyramidal cells, also receiving 
innervation from Schaffer collaterals, and from commissural fibers of the CA3. Lastly, 
the most superficial lacunosum-moleculare layer, adjacent to the dentate gyrus, contains 
distal dendritic tufts of pyramidal cells, innervated by entorhinal afferents. The axons of 
CA1 pyramidal cells give local collaterals to innervate interneurons, but not other CA1 
pyramidal cells, and leave the hippocampus through the alveus, projecting primarily to 
the subiculum. 
One of the most exciting functional features of the hippocampus is its role in spatial 
representation. Pyramidal cells of the CA1 have unique spatial receptive fields, as, in 
contrast to sparse baseline firing activity, they discharge at high frequency in specific 
places of the environment (O'Keefe and Dostrovsky 1971). This “place cell” activity is 
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maintained even in the absence of Schaffer collateral input, by the perforant path alone. 
These findings and others highlight the function of the hippocampus and the CA1 
circuit as an integrator of complex, highly processed sensory representation, exhibiting 
both pattern completion and pattern separation, encoding the spatial, temporal, 
sequence, and contextual features of events (Moser et al. 2008). Inhibition plays a 
fundamentally important role in these functions, by balancing excitation, maintaining 
and modulating rhythmic activity, tuning the firing of pyramidal cells, and filtering 
dendritic integration. Understanding the diverse network role of IN subtypes in the 
hippocampal circuit is one of the long-standing and most exciting challenges of 
neuroscience (Freund and Buzsaki 1996; Roux and Buzsáki 2015; Somogyi and 
Klausberger 2005). In the next chapter, I will briefly introduce the diversity of 
inhibitory interneurons of the CA1. 
1.2.3. Diversity of interneurons 
What defines an interneuron subtype? GABAergic interneurons, while they are ten 
times less numerous compared to the relatively homogenous pyramidal cells, exhibit 
substantial variability. This variability constitutes in their different developmental 
origins, specific organization of input and output synapses, molecular expression 
patterns, intrinsic electrophysiological properties such as discharge modes, and their 
characteristic firing patterns in intact circuits in vivo (Klausberger and Somogyi 2008; 
Markram et al. 2004). As none of these features define clear, uniform types of 
interneurons, classifications based on just one parameter often lead to contradictions. 
Nevertheless, despite the presence of many axes in the multidimensional space of 
diversity, specific types of interneurons are defined, and the existence of disjunctive 
clusters of cells can be identified based on their transcriptome (Tasic et al. 2016; Telley 
et al. 2016; Zeisel et al. 2015). The most striking anatomical feature of interneurons is 
the specialized targeting of distinct subdomains of postsynaptic pyramidal cells. Based 
on preferential target profiles, there are perisomatic interneurons, targeting the somata 
and proximal dendrites of neurons, dendritic interneurons, synapsing on the basal and 
apical dendrites, tuft-targeting cells, which selectively innervate the most distal 
segments of the dendritic tree, and axo-axonic cells, which preferentially target the axon 
hillock and axon initial segment. It is important to note, however, that cells belonging to 
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the same morphological type can be very different in every other parameter (Freund and 
Katona 2007). 
The neurochemical classification of interneurons is based on the combinatorial 
expression profile of calcium binding proteins and neuropeptides, which is strongly 
related to the developmental origin of the cell. Cortical interneurons, unlike pyramidal 
cells, are not generated in the ventricular zone of the given brain area, but are produced 
in the ganglionic eminences at the lateral ventricle of the ventral telencephalon (Butt et 
al. 2005; Wonders and Anderson 2006). Typically, interneurons derived from the 
medial ganglionic eminence express either parvalbumin (PV) or somatostatin (SST), 
while neurons from the central ganglionic eminence express reelin or vasoactive 
intestinal polypeptide (VIP). More recently, a three-way classification based on 
mutually exclusive expression of PV, SST or ionotropic serotonin receptor 3A has been 
suggested (Lee et al. 2010b; Rudy et al. 2011). In the hippocampus, a considerable 
fraction of interneurons is derived from the preoptic area of the hypothalamus. Again, it 
has to be stressed that interneurons expressing one of these markers can show 
significant heterogeneity in their other parameters (Klausberger and Somogyi 2008). 
During electrophysiological recordings, the most straightforward identification of 
an interneuron is the response it displays upon current injections. The types of discharge 
patterns include fast spiking (non-accommodating), bursting, regular-spiking 
(accommodating), irregular spiking and stuttering. Relying solely on intrinsic properties 
to identify neurons, however, can be misleading, as multiple subtypes can display 
indistinguishable electrophysiological responses (Markram et al. 2004).  
Finally, the timing of interneuron firing in relation to oscillatory network activity, 
and the recruitment of interneuron activity by feedforward or feedback circuits are 
critical parameters in understanding their function in vivo. Based on the above detailed 
parameters, Klausberger and Somogyi in their classical work have used an immense 
body of accumulated knowledge to outline 21 distinct classes of GABAergic 
interneurons in the CA1 region (Bezaire and Soltesz 2013; Klausberger and Somogyi 
2008; Somogyi and Klausberger 2005). In this study, I will focus on specific types of 
these interneurons, the few classes that express CB1 cannabinoid receptors. 
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1.3. Subtypes and roles of CB1–expressing interneurons in the CA1 
1.3.1. Distinctive features of CB1-expressing interneurons 
The first evidence for the presynaptic expression of CB1 on axon terminals came 
from interneurons of the CA1 region (Katona et al. 1999). These cells were containing 
the neuropeptide cholecystokinin (CCK), and were morphologically characterized as 
perisomatically targeting (also called basket cells, based on the basket-like appearance 
of their axon terminals enclosing pyramidal cell somata in the neocortex). Later studies 
identified more subtypes of CCK-positive interneurons, including VIP or vesicular 
glutamate transporter 3-positive cells and dendritically-targeting interneurons (Ali and 
Todorova 2010; Cope et al. 2002; Lee et al. 2010a; Somogyi et al. 2004). Thus, CB1-
positive cells can be divided into three morphological categories: one perisomatically 
targeting type (basket cells), and two dendritically-targeting types, Schaffer collateral-
associated and perforant path-associated cells. Each of these morphological types 
express regular spiking (accommodating) firing pattern, and are often reciprocally 
connected through both chemical and electrical synapses. Although all CCK-positive 
cells express CB1, and both markers can be used interchangeably for many purposes, it 
is noteworthy that not all CB1-positive cells express CCK, and single-cell 
transcriptomic studies identified multiple CB1-positive cell types (Bezaire and Soltesz 
2013; Zeisel et al. 2015). Another feature of CCK/CB1 interneurons that separates them 
from other interneurons is their role in integration of the excitation from multiple 
afferents of the hippocampus. These cells receive specific input from modulatory 
brainstem nuclei, and express postsynaptic receptors for serotonin and acetylcholine, 
and presynaptically, on their axon terminals, estrogen and GABAB receptors (Freund 
and Katona 2007). 
The inhibition delivered by CCK/CB1-positive cells is characterized by 
asynchronous GABA release. Presynaptically, they express N-type (Cav 2.2) calcium 
channels, which are loosely coupled to the vesicle release sites (Hefft and Jonas 2005). 
The asynchronicity of release is further aggravated by activity of CB1 receptors (Ali and 
Todorova 2010). 
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1.3.2. Role of CB1–expressing interneurons in network function 
Although CCK/CB1-expressing interneurons are not numerous in the CA1, they 
have a fundamental role in the regulation of pyramidal cell networks. During rhythmic 
network activity, these cells discharge at the phase of theta oscillation when place cells 
(pyramidal cells within their place field) fire (Klausberger et al. 2005). This pattern, 
together with the plasticity endowed by CB1 expression led to the hypothesis that these 
cells are important in the generation of neuronal assemblies and promoting sparse 
coding, by effectively suppressing pyramidal cell populations, while place cells firing at 
higher rate can lift the inhibition from CB1-positive interneurons via endocannabinoid 
signaling (Freund and Katona 2007). 
Recent studies revealed that CCK/CB1-positive interneurons are also important in 
regulating dendritic integration and synaptic plasticity, as well as gating excitation in 
pyramidal cells. Surprisingly, CCK/CB1 cells provide by far the strongest feedforward 
inhibition recruited by Schaffer collateral activity, the downregulation of which is a 
major component of the potentiation of entorhino-hippocampal (perforant path) 
synapses (Basu et al. 2013). Moreover, long-range inhibitory projections from the 
entorhinal cortex selectively inhibit CCK/CB1 interneurons, which underlies the gating 
of entorhino-hippocampal information flow (Basu et al. 2016). 
1.4. Super-resolution microscopy methods 
1.4.1. Principle of super-resolution microscopy 
Fluorescence microscopy is one of the most widely applied methods in life 
sciences, due to the relative ease of use, versatile labeling modes, and potential for real-
time dynamic observations. The resolution of any far-field microscope is limited by the 
diffraction of the rays used for imaging, photons in the case of light microscopy. This 
diffraction limit, often called Abbe’s law, comes from the fact that imaging is the 
reverse of projection, and just as light cannot be focused to an infinitely small spot, the 
image of a very small light source can also not be infinitely small. Thus, if the size of 
the light source is below half the wavelength of the light, the resulting image does not 
depend on the size or shape of the light source, but only on some parameters of imaging, 
namely the wavelength of light, the refractive index of the imaging medium, and the 
numerical aperture of the objective. This image, called the Airy-disc, or point spread 
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function (PSF), is a Gaussian spot surrounded by a series of ever fading rings. As a 
result, light sources that are close together, cannot be separated based on their image. In 
other terms, the PSF is the highest spatial frequency the microscope can transmit. Due 
to physical limitations, glass objectives cannot resolve two neighboring point-like 
emitters if they are separated by less than 200 nm (Requejo-Isidro 2013; Tønnesen and 
Nägerl 2013). This distance is an order of magnitude larger than macromolecules, and 
in the size range of synapses and dendritic spines, thus, for biological applications of 
light microscopy, the diffraction limit was indeed a limitation, already in the time of 
Cajal. Electron microscopy, by using electrons instead of photons and electromagnetic 
lenses instead of glass, can achieve extremely high resolutions, exceeding the 
requirements of biological applications; however, it has its own limitations. Pre-
embedding immunogold electron microscopy is able to reveal endogenous protein 
distribution with sufficient resolution, but it suffers from low sensitivity, and from the 
possibility of artefacts due to the required strong aldehyde fixation and resin 
embedding. High pressure freezing and replica labeling has the ability to reveal 
distribution with superior sensitivity and resolution, but it is limited to proteins located 
in randomly fractured membrane areas instead of complete anatomical profiles (Tanaka 
et al. 2005). Importantly, none of these methods can be applied on live, dynamic 
samples. 
In the past decades, while the theory of the diffraction limit remained valid, 
multiple innovative approaches, collectively termed super-resolution microscopy, 
enabled fluorescence imaging with up to nanometer-scale resolution (Godin et al. 2014; 
Maglione and Sigrist 2013; Oddone et al. 2014; Yamanaka et al. 2014). The numerous 
published methods are all using one of the following three independent approaches to 
break the diffraction limit. The first group of methods is based on reversible saturable 
optical fluorescence transition, and, similarly to a confocal microscope, is using laser 
scanning. The most widespread variant, stimulated emission depletion microscopy 
(STED), works by pairing the excitation beam with a doughnut-shaped depletion beam 
with a non-diffraction-limited  zero intensity spot at the center, to prohibit fluorescence 
emission from the periphery of the excitation beam, and thus, to engineer the effective 
excitation PSF to be smaller than dictated by diffraction (Hell and Wichmann 1994). 
This does not improve the imaged PSF, however, as the microscope is performing raster 
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scanning of one pixel at a time, it is known that the detected fluorescence is always 
originating from the zero intensity spot of the STED beam. The confinement of this spot 
is determined by laser power, thus, in biological applications, the resolution is in the 
range of 25-50 nm (Tam and Merino 2015). The second group of methods is called 
structural illumination microscopy (SIM). In this method, multiple widefield images are 
acquired on a camera from the same field of view, each illuminated with a different 
pattern. The interference fringes (Moiré pattern) in the resulting images carry high-
frequency spatial information of the sample in one direction in a lower frequency, which 
can be resolved by the microscope. An image with increased resolution thus can be 
calculated from all the images taken with different directions of the illumination pattern 
(Gustafsson 2000). The theoretical limit of resolution improvement using SIM is 
twofold, practically 120 nm. 
The third group of methods, single molecule localization microscopy (SMLM), is 
based on the temporally separated detection of light from individual emitters, and 
includes photoactivation localization microscopy (PALM) and stochastic optical 
reconstruction microscopy (STORM) (Betzig et al. 2006; Hess et al. 2006; Rust et al. 
2006). These are based on the switching between non-fluorescent and fluorescent states 
of individual molecules, fluorescent proteins and organic dyes, respectively (Allen et al. 
2013). In the present study, we have been utilizing STORM, thus, I will focus on this 
method in details. The limit that diffraction poses on resolution applies to the case of 
simultaneous imaging of multiple fluorescence emitters with spatially overlapping 
PSFs. The position of a single emitter, or several emitters present in a sufficiently low 
density, however, can be determined with great accuracy, by calculating the centroid of 
the PSFs. This method has been in use for single particle tracing since the 1980s (Gelles 
et al. 1988; Oddone et al. 2014). To exploit the precision of single molecule localization 
in densely labeled samples, it is necessary to control the fluorescence of emitters to 
maintain simultaneous emission from multiple sources at a very low density. Upon 
continuous illumination of the entire field of view with sufficiently high light intensity, 
the photoswitchable fluorophores emit photons, and, after a short time, enter a non-
fluorescent state. This transformation is reversible, in contrast to photobleaching which 
involves irreversible oxidation of the fluorophore. After sending the fluorophores within 
the field of view to dark state, the stochastic return to excitable state results in the sparse 
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blinking of individual fluorophores, which can be recorded on a fast camera to calculate 
the position of each event and reconstruct the spatial distribution of the signal (Rust et 
al. 2006). 
Although the principle of STORM does not require any special modification to the 
microscope or treatment of the sample to work, several improvements were necessary to 
make it practical for imaging biological samples. In recent applications, both the 
conversion of fluorophores to dark state and the return to excitable state are controlled 
to achieve optimal conditions. First of all, a more stable dark state is obtained by the 
covalent binding of a thiol group from chemicals of the special imaging medium, and 
irreversible photobleaching is avoided by the constant enzymatic scavenging of reactive 
oxygen species (Dani et al. 2010; Dempsey et al. 2009; Rust et al. 2006). Activation of 
fluorophores, i.e. increasing the probability to return to excitable state, is necessary to 
build adequate reconstruction of the sample within practically manageable time. For 
optimal results, oblique illumination with a laser TIRF illuminator, a sensitive electron 
multiplying EMCCD or scientific complementary metal–oxide–semiconductor camera, 
and a high numerical aperture TIRF objective has been used (Barna et al. 2016; Dani et 
al. 2010). 
The method for activation differentiates two approaches. The original reports of 
STORM used activator-reporter dye pairs, that is, labeled the probes with two different 
dyes, one used for imaging (reporter), and one not excited during acquisition, but 
periodically illuminated with low-intensity light (activator). The spatial proximity of the 
two dyes results in the probabilistic return of the reporter to excitable state after the 
activator is illuminated, through a mechanism which is to date not understood. In this 
configuration, acquisition is performed through cycles of one activation and multiple 
imaging frames (Rust et al. 2006). In the second approach, known as direct STORM or 
dSTORM, a single dye species is activated directly, without the involvement of a dye, 
with higher energy (405nm) photons (Heilemann et al. 2008; van de Linde et al. 2011). 
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1.4.2. Multi-channel and three-dimensional STORM imaging 
One of the most attractive features of fluorescence microscopy is the ease of 
multiplexing different labels by exploiting the specific excitation and emission 
wavelengths of different dyes. It is possible to perform simultaneous or sequential 
multi-channel imaging also with STORM using three different approaches. Firstly, 
when using activator-reporter dye pairs, multiple probes can be labeled with the same 
reporter, but different activator dyes to selectively activate each subset of probes (Bates 
et al. 2012; Bates et al. 2007; Shroff et al. 2008). Thus, by alternating the wavelength 
used for activation, blinking events detected immediately after activation can be 
assigned to the respective channel. The advantages of this method are that it allows 
simultaneous detection of multiple channels, and that it doesn’t suffer from chromatic 
aberration. The drawback is that channel assignment is probabilistic, and thus crosstalk 
between channels is inevitable (Dani et al. 2010). The second approach relies on the 
separation of emission from different reporter dyes using optical filters, which is 
becoming more available as an increasing number of fluorophores are being tested for 
SMLM (Dempsey et al. 2011; Lehmann et al. 2015a; Lehmann et al. 2015b). This 
method rules out crosstalk, but doesn’t allow simultaneous acquisition of channels, and 
introduces chromatic aberration. Finally, multi-channel imaging with spectral unmixing 
of different reporters allows simultaneous detection and prevents crosstalk, however, it 
requires splitting the emitted light and thus reduces intensity (Bates et al. 2012; Lampe 
et al. 2012; Zhang et al. 2015). 
Thus far, I’ve focused on the two-dimensional resolution of microscopic images, 
and methods improving lateral resolution. However, the diffraction limit also applies for 
axial resolution, which is, in widefield microscopy, very poor. Confocal microscopy can 
significantly improve this by rejecting off-focus light using a pinhole in the back focal 
plane of the objective, but the achieved resolution is still low (>500 nm). Each of the 
aforementioned three domains of super-resolution microscopy have developed means to 
achieve super-resolution in the axial dimension too. In STORM, this is achieved 
exploiting astigmatism (Huang et al. 2008b). By placing a cylindrical lens in the light 
path at the camera port of the microscope, the image of the emitter is not affected if the 
emitter is located exactly at the focal plane of the objective. However, if the emitter is 
out of focus, the image is elongated horizontally or vertically depending on the axial 
DOI:10.14753/SE.2017.1972
26 
 
position in relation to the focal plane. After calibration with sub-resolution emitters 
immobilized in a monolayer on the coverslip surface, the axial position of each blinking 
event can be determined from the parameters of an ellipse fitted on the distorted image 
of the emitter. Using this method, 3D-STORM images with an axial resolution of 40 nm 
can be recorded from a thin volume while improvements of the method offer the 
imaging of larger volumes (Huang et al. 2008a; Lakadamyali et al. 2012; Min et al. 
2014). 
1.4.3. Determining the resolution, and visualizing STORM data 
The resolution of an SMLM image is determined by two key factors: the density of 
detected molecules and the localization precision (Oddone et al. 2014). The precision of 
determining the position of a single-molecule image is not limited by the PSF of the 
microscope or by the pixel size of the camera. While both of these factors need to be 
taken into account, the accuracy of the fitting mainly depends on the number of photons 
detected from a blinking event. This measure of resolution, called localization precision, 
can be calculated analytically, but can also be determined experimentally by measuring 
the standard deviation of the centroids of multiple localizations of the same fluorophore. 
According to the Nyquist criterion of sampling, structural features smaller than the 
double of the distance of the nearest fluorophores cannot be resolved. Consequently, the 
density of detected fluorophores also contributes to the resolution of the reconstructed 
image. Mathematical means of providing exact numerical measures of resolution are 
available in the literature (Dempsey et al. 2011; Nieuwenhuizen et al. 2013; Thompson 
et al. 2002). 
Finally, it is important to note that SMLM does not produce an image of the 
sample, but rather a list of coordinates of individual localization points. Therefore, the 
visualization of the microscopy data requires some form of rendering. The earliest 
publications simply used scatterplots of positions, which are accurate, but do not 
facilitate the intuitive interpretation of images (Rust et al. 2006). It is common in the 
literature to generate pixelated images where the greyscale intensity reflects the number 
of molecules per pixel, this method, however, sacrifices resolution at well-sampled, and 
introduces erroneous details in undersampled regions of the image (Baddeley et al. 
2010). The molecule list can also be represented with Gaussian spots at the position of 
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each localization point, with the spread of the spot representing the localization 
precision of the given point. Such images represent the information content of the 
molecule list more faithfully, and allow the rendering of the STORM image at arbitrary 
zoom level (Dani et al. 2010). 
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2. Objectives 
How the molecular composition of specific neurons underlies their circuit function 
is a fundamental question of neuroscience. However, the required integrated analysis of 
electrophysiological, structural and nanoscale molecular features of individual cells has 
been technically challenging. The CB1 cannabinoid receptor is a major regulator of 
synaptic strength throughout the CNS, but the determinants of the cell type-specific 
variability in endocannabinoid signaling are poorly understood. Therefore in this study 
our specific aims are: 
1) To develop a method for cell-specific molecular imaging 
 Evaluate whether STORM super-resolution imaging can be used for quantitative 
purposes 
 Optimize STORM for imaging CB1 distribution in brain tissue 
 Optimize the correlated acquisition and analysis of confocal and STORM 
images of individually labeled neurons 
2) To determine cell type-specific alterations in the molecular organization of synaptic 
endocannabinoid signaling 
 Compare the abundance and distribution of CB1 between perisomatically- and 
dendritically-targeting interneurons 
 Compare the nanoscale organization of synaptic active zones between 
perisomatically- and dendritically-targeting interneurons 
3) To investigate the dynamic rearrangement of CB1 receptors in response to 
cannabinoid agonists 
 Determine the effect of acute elevation of endocannabinoid levels 
 Determine the effect of chronic THC treatment 
 Determine molecular basis of the dose-dependence and recovery of cannabinoid 
tolerance 
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3. Methods 
3.1. Animals 
Animal experiments were approved by the Hungarian Committee of the Scientific 
Ethics of Animal Research (license number: XIV-1-001/2332-4/2012), and were 
performed according to the Hungarian Act of Animal Care and Experimentation (1998, 
XXVIII, Section 243/1998, renewed in 40/2013), which are in accordance with the 
European Communities Council Directive of 24 November 1986 (86⁄609⁄EEC; Section 
243/1998). All efforts were made to minimize pain and suffering, and to reduce the 
number of animals used. Perfusions for population-level STORM experiments were 
carried out on adult (postnatal day 50-60) male littermate CB1
+/+ 
and CB1
–/–
 (kindly 
provided by Prof. Andreas Zimmer, University of Bonn, Germany) C57BL/6H mice 
(Zimmer et al. 1999). Under deep anesthesia with intraperitoneal injection of ketamine–
xylazine (25 mg/ml ketamine, 5 mg/ml xylazine, 0.1% w/w pipolphen; 1 ml/100 g), 
mice were perfused transcardially with 0.9% saline for 2 minutes, followed by 4%  
paraformaldehyde (PFA) in 0.1 M phosphate buffer (PB, pH = 7.4) for 20 minutes. 
After perfusion, the brains were removed from the skull, cut into blocks and post-fixed 
in 4% PFA for 2 hours. Either 20 µm or 50 µm thick coronal sections were collected for 
immunofluorescence labeling or for immunogold staining, respectively, using a Leica 
(Nussloch, Germany) VT-1000S vibratome, and washed extensively in PB. 
Acute hippocampal slice preparations were obtained from male C57BL/6N mice 
(postnatal day 25-40). Under deep anesthesia with isoflurane, mice were decapitated, 
and the brains were quickly removed and put in ice-cold high-sucrose artificial 
cerebrospinal fluid (ACSF; in mM, 85 NaCl, 75 sucrose, 2.5 KCl, 25 glucose, 1.25 
NaH2PO4, 4 MgCl2, 0.5 CaCl2, and 24 NaHCO3, equilibrated with 95% O2 and 5% 
CO2). Cutting to 300 µm was performed on a Vibratome in ice-cold oxygenated high-
sucrose ACSF. After sectioning, slices were incubated in high sucrose ACSF for 60 
minutes at 34°C, and then transferred to an oxygenated chamber containing ACSF 
(containing in mM: 126 NaCl, 2.5 KCl, 26 NaHCO3, 2 CaCl2, 2 MgCl2, 1.25 NaH2PO4, 
and 10 glucose, equilibrated with 95% O2 and 5% CO2) for 60 minutes at room 
temperature.  
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3.2. Chronic drug treatment 
All procedures were performed in accordance with the Italian Ministry of Health 
guidelines (D.L. 116/92; D.L. 111/94-B) and EEC Council Directives (219/1990 and 
220/1990). Male C57BL/6J mice (postnatal day 22–31) were housed together (ten per 
cage), and randomly assigned to treatment groups. Individuals were identified by 
marking the tails daily with paint marks. Mice were injected twice daily 
intraperitoneally with vehicle (1% ethanol, 2% Tween 80 and saline) or THC (THC-
Pharm GmbH, Frankfurt am Main, Germany) for 6.5 days. After the last injection, mice 
were allowed to recover according to the experiment (24 hours to 6 weeks), and then 
sacrificed to prepare acute hippocampal slices as described above. 
3.3. Patch-clamp recording 
Electrophysiological recordings from pyramidal cells and interneurons were carried 
out at 33°C in oxygenated ACSF. A fixed stage microscope (Eclipse FN1, Nikon, 
Tokyo, Japan) equipped with infrared differential interference contrast optics and 
micromanipulators (Luigs & Neumann, Ratingen, Germany) was used to visualize and 
approach the cells with borosilicate glass micropipettes (3–4 MΩ) filled with internal 
solution containing 0.2% biocytin, and (in mM) 126 K-gluconate, 4 KCl, 10 HEPES, 4 
ATP-Mg, 0.3 GTP-Na, 10 phosphocreatine, pH 7.2, 270–290 mOsm. Pyramidal cells 
and interneurons located in the pyramidal and radiatum layers of CA1, respectively, 
were recorded in whole-cell patch-clamp configuration. Traces were recorded using 
MultiClamp700B amplifiers (Molecular Devices, Sunnyvale, USA). Signals were 
filtered at 3 kHz using a Bessel filter and digitized at 10 kHz with a Digidata 1440A 
analog–digital interface (Molecular Devices). The resting membrane potential was 
measured in current-clamp mode, and then the response of the cell to current steps 
(from -200 to 300 in 50 pA increments, 1s) was recorded. Then, cells were clamped to -
70 mV for 10-30 minutes to allow axonal labeling with biocytin. Series resistances were 
carefully monitored, and the recordings were discarded if the series resistance changed 
> 20% or reached 20 MΩ. The recorded traces were analyzed using the Clampfit 10.2 
software (Molecular Devices). After recording, the sections were transferred into 4% 
PFA in PB, and fixed for 40 hours at 4°C. 
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3.4. Cell culture 
HEK293 cells were maintained in cell culture treated T25 flasks in Dulbecco's 
modified Eagle's medium containing 25 mM D-glucose and 10 % heat-inactivated 
neonatal calf serum at 37 °C and 5 % CO2. For transfection with the construct coding N-
terminally EGFP-tagged CB1 (Tappe-Theodor et al. 2007), the cells were split onto 
poly-D-lysine (20 μg/ml) coated glass-bottom petri dishes. (Ibidi, Martinsried, 
Germany). Transfection was performed using 1 μg of plasmid DNA and 1 μl 
Lipofectamine 2000 (Invitrogen, Carlsbad, USA) per dish, according to manufacturer’s 
instructions. Dishes were returned to 37 °C and 5 % CO2 for 18 hours to allow the 
expression of the construct. After incubation, cells were fixed in 4 % paraformaldehyde 
for 15 minutes. 
3.5. Immunostaining 
Immunostaining in this study was used to label HEK cells and brain slices for 
confocal microscopy and STORM. All tissue samples were stained free-floating, in 24-
well tissue culture dishes, and incubations were at room temperature on an orbital 
shaker unless stated otherwise. The primary and secondary antibodies used throughout 
the study are listed in Table 1 and Table 2, respectively. 
Table 1: Primary antibodies utilized in the study 
Antigen Host species Dilution Catalogue number or reference 
Bassoon Mouse 1:2000 Ab82958, Abcam (Cambridge, UK) 
CB1 Guinea pig 1:1000   Gift of M. Watanabe (Hokkaido, 
Japan) (Fukudome et al. 2004) 
CB1 Rabbit 1 µg/ml ImmunoGenes Kft 
(Budakeszi, Hungary) (Dudok et al. 
2015) 
CCK Mouse 1:3000 #9303, CURE (Los Angeles, USA) 
EGFP Mouse 1:1000 MAB3580, Millipore (Darmstadt, 
Germany) 
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Custom-labeled secondary antibodies were prepared from unlabeled antibodies 
listed in Table 2. Amino-reactive succinimidyl ester derivatives of dyes AF405 and 
AF647 were purchased from Molecular Probes (Carlsbad, USA), and Cy3 from GE 
Healthcare (Little Chalfont, UK), and dissolved in DMSO at 0.2 mg/ml. Antibodies (50 
µl) and dyes (one activator: AF405, 4 µl or Cy3, 1.5 µl; and reporter (AF647, 0.6 µl) 
were mixed in a tube, and 6 µl of 1M NaHCO3 was added to start the reaction. After 30 
minutes of incubation at room temperature, 140 µl of DPBS was added to stop the 
reaction, and the mixture was filtered through Sephadex G-25 size exclusion 
chromatography columns (GE Healthcare). The first 550 µl of elution was discarded, 
and the next 300 µl was collected. The antibody concentration and the labeling ratio 
were determined using a spectrophotometer (SmartSpec Plus, Bio-Rad, Hercules, USA). 
Table 2: Secondary antibodies utilized in the study 
Target 
species 
Host 
species 
Label Dilution Catalogue number 
Guinea pig Donkey Custom 
Cy3 + AF647 
2 µg/ml 706-005-148,  Jackson 
ImmunoResearch (West 
Grove, USA) 
Mouse Donkey Custom 
AF405 + AF647 
2 µg/ml 715-005-150, Jackson 
Rabbit Donkey Custom 
Cy3 + AF647 
2 µg/ml 711-005-152, Jackson 
Mouse Donkey AF594 3.75 µg/ml 715-585-150, Jackson 
Guinea pig Donkey AF647 3.75 µg/ml 706-605-148, Jackson 
 
For the staining of HEK cells, petri dishes with fixed cells were washed three times 
in PB, and permeabilized for 10 minutes in 0.05M Tris-buffered saline (TBS, 0.9% 
NaCl, pH = 7.4) containing 0.1% Triton X-100. Dishes were then incubated with 
Guinea pig anti-CB1 primary antibody, and in some experiments, mouse anti-EGFP 
antibody, for 1 hr. The cells were then washed in TBS three times and stained with 
secondary antibodies (Cy3 + AF647 donkey anti-Guinea pig for single CB1, and AF594 
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donkey anti-mouse and AF647 donkey anti-Guinea pig) in TBS for 1 hr. Finally, dishes 
were washed twice in TBS and twice in PB, and stored in PB with 0.05% NaN3 until 
imaging. 
Before immunostaining, slices containing filled neurons were developed to 
visualize the biocytin labeling inside the recorded cell. After extensive washing in PB 
and TBS, slices were treated with 0.5% Triton X-100 in TBS twice for 30 minutes, and 
incubated in AF488-labeled streptavidin (1:1000, Jackson). Sections were then washed 
in TBS and PB consecutively, mounted on glass slides in Vectashield (Vector 
Laboratories, Burlingame, USA), covered with #1.5 borosilicate glass coverslips 
(Menzel-Gläser, Braunschweig, Germany), and sealed with nail polish (Crystal Nails, 
Melbourne, USA). Labeled cells were imaged by confocal microscopy (see below), and 
then the coverslips were removed and the sections returned to PB. 
For STORM experiments, sections of perfused brain or slices containing developed 
neurons were embedded in 2% agarose, and sectioned on a Vibratome to 20 µm 
thickness. Sections were washed extensively in TBS, and then incubated in blocking 
solution containing 1% bovine or human serum albumin in TBS (also containing Triton 
X-100 for perfused brain samples). Then, the sections were incubated overnight in TBS 
containing one or two of the primary antibodies (Guinea pig anti-CB1, mouse anti-CCK, 
mouse anti-bassoon, rabbit anti-CB1), washed extensively in TBS, and then incubated in 
the respective secondary antibodies for 4 hours. Finally, sections were washed again in 
TBS and PB, the hippocampi were trimmed, and mounted on glass coverslips (one 
section per coverslip) in PB, and let to dry. Coverslips were stored dry at 4°C until 
imaging. 
3.6. Microscopy 
For the imaging of cellular morphology, confocal z-stacks were recorded from the 
field of view containing the filled cell (2048 by 2048 pixels, 131 nm/px) with 0.75-1 µm 
step size and 100-150 µm range using 488 nm illumination and 20x objective (0.75 NA, 
CFI Plan Apo VC, Nikon) on an A1R or C2 confocal microscope fitted on a Ti-E or a 
Ni-E microscope, respectively (Nikon). 
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All STORM imaging was carried out on an N-STORM system, consisting of a Ti-E 
inverted microscope equipped with laser TIRF illuminator (with a 2x magnifying lens in 
the illuminator to increase power density at the center of the field), 300 mW solid-state 
647 nm laser, 405, 488 and 561 nm lasers, an Andor iXon DU-897 back-lit cooled 
EMCCD (equipped with cylindrical lens in the light path for astigmatic 3D imaging), a 
C2 confocal scanhead, and a 100x objective (1.49 NA, CFI Apochromat TIRF, Nikon).  
Before imaging each specimen, fresh imaging medium was prepared, containing 5% 
glucose, 0.1 M 2-Mercaptoethylamine (30070, Sigma, St. Louis, USA), 1 mg/ml 
glucose oxidase (G2133, Sigma) and 1500 U/ml catalase (C30, Sigma) in DPBS (Dani 
et al. 2010).  
For glass-bottom petri dishes containing HEK cells, storage buffer was removed 
and the imaging medium was added, the dish was closed air-tight and placed on the 
microscope stage. Randomly selected GFP-positive cells were first imaged in confocal 
mode, by acquiring z-stacks with sequential illumination with 488 and 561 or 647 nm 
excitation (512 by 512 by 15 voxels, 80 by 80 by 150 nm resolution. Then the 3D-
STORM image of the same field of view was acquired for each cell (2000 cycles of 1 
activation (561 nm, low power) and 3 reporter (647 nm, maximal power) frames each, 
30 ms exposure time) using STORM filter cube (excitation by any line, emission in far-
red). 
For tissue sections, imaging medium was spread on a slide, and then the slide was 
covered with the coverslip containing the section, sealed with nail polish, and 
equilibrated on the microscope stage for 5 minutes. Imaging was continued for up to 3 
hours after covering the sample. Axon terminals were selected by systematically 
scanning through the sample and including every eligible axon terminal (within 10 µm 
from the coverslip, field of view not overlapping with previous images from the same 
sample). Confocal z-stacks were taken as described above, and then single-channel or 
dual-channel 3D-STORM images (1000 cycles per channel, 1 activation (405 or 561 
nm, low power) and 3 reporter (647 nm, maximal power) frames, 30 ms each, per cycle) 
were recorded. For dual-channel STORM, cycles for the two channels were alternated. 
Before starting acquisition, fluorophores in the field of view were sent to dark state by 
maximal illumination with 647 nm. The protocol published by our group contains 
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additional details and recommendations for the application of the STORM method 
(Barna et al. 2016). 
3.7. Image analysis 
Low-magnification confocal images of filled neurons were analyzed in ImageJ, or 
reconstructed in Neurolucida 10 (MBF Bioscience, Williston, USA). For producing 
bouton distribution histograms and calculating BDI, the following procedure was 
applied. Stacks were loaded in ImageJ, enhanced using the Despecle and Subtract 
Background commands, and maximum intensity z-projections were generated. On 
these, the borders of the oriens, pyramidale and radiatum layers were hand-drawn based 
on the pyramidal cell nuclei, and added to ROI Manager. Then, the position of each 
visible axon terminal was clicked, saving its coordinates. Then, the distance of each 
bouton from the layer borders was calculated, normalized to the thickness of the 
pyramidal layer, converted to reflect laminar position (i.e. zero is the center of the 
pyramidal layer, negative values are towards oriens, and positive values are towards the 
radiatum), and rounded to one decimal precision. These values were used to plot 
histograms, and to calculate a bouton distribution index (BDI) from the descriptive 
statistics of all boutons of a cell according to the formula BDI = 
0.5
|𝑀|∗(Q3−Q1)
, where M is 
the mode and Q1 and Q3 are the upper and lower quartiles of the distribution, 
respectively. This index is vulnerable in case of multimodal distributions, therefore in 
such cases, the histogram was inspected to reveal any possible mismatch. If two modes 
were in adjacent bins, the mean of the two modes was used. 
High magnification confocal stacks (used for correlated STORM analysis) were 
deconvolved with Huygens Professional (SVI, Hilversum, Netherlands) using 
theoretical PSF (based on the optical parameters of the imaging) and classic maximum 
likelihood estimation algorithm, 100 iterations. STORM images were processed with 
NIS Elements STORM Module (Nikon) using the same experimentally determined z-
calibration curves and identical peak thresholds for all images. For dual-channel 
STORM images, crosstalk correction was performed with identical parameters for all 
images. Image-based drift correction was enabled. The resulting molecule list, 
containing the drift corrected, 3-dimensional coordinates and the channel assignment of 
each localization point (LP, one blinking event was considered one LP even if the event 
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lasted several frames) in the field of view, were exported in text format for further 
analysis. 
To select the LPs belonging to the filled axon terminal of the labeled neuron, 
deconvolved confocal stacks were loaded in ImageJ, enhanced using the Despecle, 
Subtract Background and Enhance contrast commands, and the three central optical 
sections, corresponding to the volume covered by the 3D-STORM image, were 
maximum intensity z-projected. These images were then transformed using the 
TurboReg plugin based on a calibration to remove most of the differences in 
magnification, rotation and translation between confocal and STORM image of the 
same field of view. The text file containing STORM coordinates was read. Then, with 
only the biocytin channel displayed, a rectangular selection was made around the 
labeled axon terminal. The confocal image within the rectangle was copied, transformed 
to RGB color image to display all channels, and rescaled to 1 nm per pixel resolution. 
Then, each STORM LP was checked if it is within the rectangular region, and included 
points were transformed to match the rescaled and cropped confocal region and 
displayed on the image as a multipoint ROI with 1 nm precision. To eliminate any 
remaining mismatch between the confocal and STORM image, the confocal image was 
moved manually until the STORM and the corresponding confocal channel were in 
perfect alignment, while the LP positions remained unaltered. Finally, the outline of the 
biocytin-positive axon terminal was drawn manually, and STORM points within this 
shape were identified, and their coordinates and channel assignments were saved as a 
text output. The size of this region, and the number of included points were saved and 
used for the area, perimeter and NLP measures. Morphological descriptors were also 
measured using built-in ImageJ functions. These are dimensionless numbers reflecting 
the following ratios: circularity is the ratio of the area and perimeter normalized to that 
of a circle, aspect ratio is the ratio of the axes of a fitted ellipse, and solidity is the ratio 
of the area of the shape over its convex area. 
The saved molecule lists were used for all the subsequent measurements and 
analyses carried out using custom-written scripts in ImageJ, Matlab or Python 
languages. Specific analysis methods are explained in the Results chapter together with 
DOI:10.14753/SE.2017.1972
37 
 
the relevant biological context, and are described in detail in the original publication 
(Dudok et al. 2015). 
Visualization of the STORM images was obtained with NIS-Elements STORM 
module as two-dimensional Gaussian representations, or with VMD (University of 
Illinois, USA), which is a program for three-dimensional visualization of molecule 
structures. To feed STORM data to VMD, LPs were converted to pdb format, originally 
used to store positions of atoms. Each LP was added as an atom (using the measured 
position of LPs), and convex hull edges were added as bonds. Color coding was 
assigned either as different atom types for channels, or as separate chain identifiers for 
clusters. 
3.8. Statistical analysis and figure preparation  
Statistical analysis was performed and graphs were plotted using Statistica 10 (Dell, 
Round Rock, USA). Before selecting the appropriate probe for hypothesis testing, 
samples were evaluated whether data points from different cells or animals of a group 
can be pooled using nonparametric Kruskal-Wallis ANOVA. If the test revealed no 
difference between cells or animals of the group in any of the groups, the data points 
were pooled. Otherwise, the mean of each cell or animal was calculated and used for 
further analysis. The resulting sample was then tested for normality and equality of 
variances using Saphiro-Wilk test and F-test, and the histograms were inspected. 
Typically, the properties of the samples did not meet the assumptions of parametric 
probes, thus, nonparametric probes were used. For the comparison of two groups, 
Mann-Whitney U test with continuity correction (two-sided) was used if the sample 
sizes were comparatively low (<20) for its power to detect differences if the means of 
groups are different. For larger samples, two-sample Kolmogorov-Smirnow test was 
used, for it is less likely to produce false positive results with increasing sample size, 
and is more sensitive to detect differences in distributions even if the means are not very 
different. For comparisons of multiple independent groups, Kruskal-Wallis ANOVA 
was used, with post-hoc median test for multiple comparisons if difference between 
groups was detected. Data were presented as scatterplots, histograms, cumulative 
histograms or box plots. 
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For the selection of individually sized bouton populations from the two cell types, 
the following algorithm was used. First, the sizes, and individual and group identifiers 
of all available boutons were read into the input sample. Then, boutons with size outside 
the interdecimal range of their respective group were discarded to avoid including 
extremes. Next, a bouton from one (source) group was selected at random, and the 
bouton from the opposite (pair) group with the least difference in size was found. Both 
boutons were added to the output sample and removed from the input, and this process 
was continued alternating the source and pair groups until the output sample contained 
the desired number of boutons. 
For figure preparation, unmodified digital micrographs were converted to 8-bit 
RGB images, and edited and labeled using Photoshop CS5 (Adobe, San Jose, USA). In 
case of correlated confocal and STORM images, snapshots of the Gaussian 
representations were generated, overlaid and manually transformed to match the 
corresponding confocal image, and, in some cases, cropped for the region of the labeled 
axon terminal. Note that this method is different and independent from the more precise 
method used for analysis (which uses coordinates instead of a rendered image), but it is 
still appropriate to create faithful representations of the STORM LPs belonging to a 
labeled profile. Confocal images of multiple samples presented in the same figure were 
modified jointly and identically during every step to preserve any differences. 
Adjustment to contrast and gamma correction were done to facilitate inspection by 
humans. All microscopic images are false colored, and hue was adjusted for each 
channel to meet the color composition of the given figure. For most of the correlated 
confocal-STORM image pairs, the confocal images were resized using nearest neighbor 
resampling to preserve the edges of original pixels, except for Figure 10, where bicubic 
resampling was used to smoothen the outline of the axon.  
 
3.9. Personal contribution to the results 
The results presented in this study are a result of a collaborative effort, and several 
researchers provided invaluable samples, reagents, microscopy- and programming 
support. My contribution was central in solving the technical challenges of microscopy 
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and image processing, planning experiments, capturing, analyzing and interpreting 
microscopy data, and preparing figures. 
HEK cells were maintained and transfected by Christopher Henstridge (Figure 2), 
and László Barna recorded most of the STORM images of HEK cells. I have performed 
immunostaining and part of the imaging, and image analysis (Figure 3). 
Immunostaining and STORM for Figure 6 was carried out by Eszter Szabadits and 
László Barna. I have analyzed the data and prepared the figure. For all experiments 
involving individually filled neurons, all patch-clamp recordings and analysis of 
electrophysiological data were performed by Marco Ledri, Szilárd Szabó, and Sang-Hun 
Lee. I have carried out the morphological analysis and reconstruction of cells, and the 
immunostainings with technical assistance from Balázs Pintér. During experiments with 
high sample numbers, I have collected the vast majority of STORM images, while 
Stephen Woodhams and Szilárd Szabó contributed with collecting some of the images. I 
have developed the method for the correlated visualization and analysis of confocal and 
STORM images, and processed and analyzed all images. For molecular distance (Figure 
15), and clustering calculations (Figure 16), I have acquired and processed the images, 
and analyzed the results, while László Barna performed the distance or cluster analysis 
on the data sets. Chronic and acute drug treatments were done by Claudia Sagheddu and 
Sang-Hun Lee, respectively, and I performed the processing, imaging and analysis of 
the samples. I have performed all the statistical analysis, and prepared all the figures in 
the study, except for Figure 1, which is the work of László Barna. 
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4. Results 
4.1. STORM super-resolution imaging in cell culture model 
4.1.1. Assessing the quantitative power of STORM 
To validate the use of STORM for studying the nanoscale subcellular distribution 
of CB1 cannabinoid receptors, we have first used the simplified model of a heterologous 
expression system before turning to complex brain tissue specimens. Human embryonic 
kidney cells (of the HEK-293 cell line) were cultured under routine adherent cell culture 
conditions, and were transiently transfected with a plasmid DNA containing the coding 
sequence of the human cnr1 gene (encoding the CB1 protein) fused with the coding 
sequence of the fluorescent protein EGFP, driven by a viral promoter. This construct 
has been shown to express a chimeric CB1 protein tagged N-terminally with EGFP 
(EGFP-CB1), which is transported to the plasma membrane of HEK cells (Tappe-
Theodor et al. 2007). After fixing and permeabilizing the cells, we have carried out 
indirect fluorescent immunostaining with a polyclonal primary antibody raised against 
EGFP or CB1. For the detection of primary antibodies, we have used custom-made 
secondary antibodies, which were produced by conjugating IgG molecules with reactive 
versions of the small organic fluorescent dye molecules AF647 and Cy3 (Figure 1). 
While AF647 is bound to the IgG at a low stoichiometry (less than one dye per protein 
molecule), Cy3 is bound at a ratio of over 2:1. This configuration allows the detection 
of AF647 as a reporter, and the use of Cy3 as an activator during STORM imaging 
(Rust et al. 2006). 
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Figure 1. Schematic drawing of the experimental setting for correlated 
confocal and STORM imaging of chimeric molecules. CB1 receptors labeled by a 
genetically encoded fluorescent tag and by immunostaining can be detected with two 
independent methods using confocal and STORM imaging modalities (Dudok et al. 
2015). 
After immunostaining, EGFP-CB1 can be imaged using conventional fluorescence 
or confocal microscopy by detecting the intrinsic fluorescence of EGFP, and also by 
using STORM to detect the reporter dyes (Figure 1). Thus, if the anti-CB1 
immunostaining and STORM imaging are sensitive and specific, both methods of 
detection are expected to display similar spatial distribution. Moreover, if the number of 
detected molecules in STORM is proportional to the number of CB1 proteins, the 
relative intensity of several individual cells with variable expression levels is expected 
to change in a correlated manner between the confocal and STORM images. To test 
these hypotheses, we have compared correlated image pairs of transfected HEK cells 
captured with constant acquisition settings. These image pairs demonstrated that the 
distribution of the signal is qualitatively similar between the confocal and STORM 
images of the same cell (Figure 2). Cells that didn’t show GFP fluorescence 
(untransfected cells in the culture) had negligible levels of STORM signal, confirming 
the specificity of the staining and the imaging process, and indicating that HEK cells 
don’t express native CB1 receptors. 
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Figure 2. Correlated confocal and STORM images of a representative HEK 
cell expressing EGFP-CB1. (a) Confocal image of the intrinsic EGFP fluorescence 
demonstrates the targeting of the construct to the plasma membrane. (b) STORM image 
of the anti-CB1 immunostaining of the same cell reveals similar distribution of the two 
types of detected signal. (c) High magnification view of the boxed region from panel (a) 
shows the blurred nature of the confocal image, due to limited resolution. (d) In 
contrast, the high power STORM image provides sharp visualization of the plasma 
membrane of the cell (Dudok et al. 2015). 
Our next goal was to determine whether the quantification of localization points 
(LP) in the STORM data is a reliable way to measure relative protein abundance. To 
answer this question directly, one would need to take STORM images of 
immunostained samples with a series of known protein concentrations, and define the 
dynamic range within which the number of localization points (NLP) is linearly 
correlated to protein concentration. However, it’s not trivial to perform such an 
experiment, especially not in a setting that mimics the cellular environment in which 
biological measurements are carried out. Using the EGFP fluorescence to measure the 
relative protein concentration across samples, however, is feasible, assuming that the 
number of detected photons is related to the number of excited molecules. Indeed, 
fluorescence intensity of confocal images has been used to determine the copy number 
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of EGFP-tagged molecules (Verdaasdonk et al. 2014). Staining the samples using 
antibodies, however, may introduce additional limitations for quantification, as the 
concentration of bound antibodies may not follow the concentration of epitopes in a 
linear fashion. On the other hand, it has been shown that under well-optimized 
conditions, anti-EGFP immunostaining can reliably report EGFP levels (Mortensen and 
Larsson 2001). On confocal images of our HEK cell samples, intrinsic EGFP 
fluorescence was strongly correlated to the intensity of indirect fluorescent anti-CB1 
immunostaining (Figure 3a), indicating that the expression level of the construct, the 
concentration of primary and secondary antibodies, and the detector settings of the 
confocal microscope were adequate for the reliable measurement of 
immunofluorescence intensity (n = 65536 pixels from one representative image, 
Spearman’s rank order correlation, R = 0.97, p < 0.0001). 
 
Figure 3. Immunostaining and STORM microscopy is a valid method to probe 
molecular abundance. (a) Pixels of a confocal image of a representative EGFP-
expressing HEK cell immunostained against CB1 have strongly correlated intensity 
values in both the intrinsic EGFP fluorescence and the immunofluorescence channels. 
(b) On the contrary, the intrinsic EGFP fluorescence intensity of pixels is weakly 
correlated to the NLP in the corresponding area of the anti-EGFP STORM image, due 
to the different spatial resolution of the two imaging modalities. (c) On the level of 
individual cells immunostained against CB1, however, the total EGFP fluorescence from 
the cell is in strong correlation with the NLP in the STORM image. 
The stochastic nature of single molecule localization microscopy raises the question 
whether the method is suitable for quantification. As the number of detected blinking 
events is highly variable between individual fluorophores, it is obvious that one LP on a 
STORM image does not correspond to one epitope in the sample (Dempsey et al. 2011). 
However, if the density of LPs in a given part of the image is proportional to the 
concentration of epitopes in the corresponding volume of the sample, the NLP can be 
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used as a proxy to determine the relative number of proteins. To test this hypothesis, we 
have investigated the relationship between intrinsic EGFP fluorescence intensity of 
individual pixels of confocal images, and the NLP from anti-EGFP immunostaining in 
the corresponding areas of STORM images (Figure 3b). Due to the unavoidable poor 
pixel-level alignment of the confocal and STORM signals, caused by the different 
resolutions of the two imaging modalities, we have found only weak correlation of 
intensity levels (n = 65536 pixels from one representative image, Spearman’s rank order 
correlation, R = 0.63, p < 0.0001). 
Thus, to determine whether anti-CB1 STORM labeling intensity follows EGFP-CB1 
levels, we have imaged several fields containing individual HEK cells with varying 
expression levels. Comparison of the integrated signal intensities from whole image 
fields revealed strong correlation between the measurements obtained by either confocal 
or STORM microscopy (n = 46 cells from 5 coverslips, Spearman’s rank order 
correlation, R = 0.92, p < 0.001). The STORM NLP followed EGFP fluorescence 
intensity in a linear fashion in the medium range of expression levels (Figure 3c). In the 
high and low extremes of expression levels, however, the confocal intensities were 
above the linear fit. This can be explained by assuming that either STORM 
underestimates, or confocal imaging overestimates signal intensity. At the most strongly 
expressing cells, STORM detection of immunostaining may be confounded by 
saturation effects such as the spherical limitations of antibody crowding, and/or the 
overlapping blinking of fluorophores interfering with single molecule detection. 
Contrary, on the low end, STORM is supposed to be very sensitive in detecting low 
density signal, as the signal-to-noise ratio (SNR) for even one molecule is sufficient for 
detection, while confocal imaging is more affected by background fluorescence and 
Poisson noise, preventing the detection of weak signal. Taken together, this experiment 
demonstrates the validity of quantitative STORM experiments in biological sample. 
4.1.2. Optical sectioning properties of 3D-STORM 
The imaging strategy used throughout this study to determine the z coordinates of 
STORM LPs relies on the astigmatic distortion of the single-molecule images of 
blinking fluorophores (Huang et al. 2008b). While this method allows the recording of 
volume images with super-resolution accuracy in all three dimensions without scanning 
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the sample, it is important to note that the sensitivity of detection is diminishing quickly 
with increasing distance from the focal plane. This effect is due to the fact that the 
single emitter image distorted by the cylindrical lens is spread over a larger area than 
the original image, resulting in reduced SNR, and thus, reducing the probability of 
successful detection. Moreover, as the spherical aberrations in the image are minimal 
for emitters between the coverslip and the focal plane, but are worse for emitters located 
deeper than the focal plane, the decrease in detection sensitivity is also asymmetrical. 
As a result of these issues, a single 3D-STORM image can contain LPs within 600 nm 
distance from the focal plane, the probability of detecting a blinking event is only 50% 
already at 100 nm axial distance (Figure 4). Consequently, a single 3D-STORM image 
can be regarded as an optical section, but without a definite thickness. We have found 
empirically that the optical section of one STORM image corresponded to the maximum 
intensity projection of three neighboring confocal slices (using 150 nm step size). 
 
Figure 4. Histogram of the axial coordinates in a 3D-STORM image. 
Distribution of LPs from the whole CB1 STORM image of a representative EGFP-CB1-
expressing HEK cell. Note the asymmetrical decrease in the number of points with 
increasing distance from the focal plane (z = 0). The full width at half maximum of the 
Gaussian fit is 352 nm. 
4.1.3. Determining the localization precision of STORM images 
Superior spatial resolution is the main advantage of single molecule localization 
microscopy over standard methods of fluorescence microscopy. Localization precision 
can be determined directly by imaging immobilized fluorescent dye molecules, and 
fitting a Gaussian function on the calculated positions over multiple detections of the 
same molecule. But the resulting values may not necessarily reflect the quality of 
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images taken from biological samples. Since the accuracy of positioning detected 
blinking events largely depends on the SNR of the individual fluorophore images and 
sample stability, it is imperative to measure localization precision under imaging 
conditions that are equivalent to the conditions of collecting the actual data, or, more 
practically, on the same image. This is possible by evaluating isolated clusters of 
multiple blinking events, presumably originating from single, non-specifically bound 
secondary antibodies. As these clusters don’t contain enough LPs for fitting, we have 
selected several clusters, and pooled all clusters by aligning them on their centers of 
masses (Figure 5). 
 
Figure 5. Fluorophore localization precision in the CB1 STORM images of 
HEK cells. (a) Scatterplots of the lateral coordinates of the LPs from the pooled clusters 
of multiple detections of fluorophores. The sparseness of points at the origin of the 
graph is due to the low number of LPs in individual clusters, resulting in the absence of 
a point at the center of mass of most clusters. (b) Scatterplot of the axial coordinate 
reveals larger localization error of the z coordinate. Note that the scale values are 
different between panels a and b. (c-e) Histograms of the values of coordinates (grey), 
with the Gaussian fits (red lines) and the calculated standard deviations. All coordinates 
are in nanometers. 
DOI:10.14753/SE.2017.1972
47 
 
For the calculation of localization precision, clusters containing altogether 1220 
LPs were selected from 5 randomly picked STORM images of CB1 immunostaining. 
The standard deviations of the coordinates were 5.7 nm in the lateral and 32.1 nm in the 
axial dimensions, respectively (Figure 5c-e). 
4.2. STORM super-resolution imaging of cannabinoid receptors in brain tissue 
4.2.1. Validating the immunostaining and imaging protocol 
The first studies that introduced the STORM imaging technique have been using 
samples such as fluorescently labeled cell-free DNA (Rust et al. 2006), synthetic 
microtubules (Dempsey et al. 2011), or in vitro cell cultures (Bates et al. 2007). These 
types of samples allow the acquisition of images with excellent SNR from the 
immediate vicinity of the coverslip. While others have successfully implemented 
STORM for cryosections from fixed brain tissue (Dani et al. 2010), directly following 
published protocols was not adequate for achieving our goal, the imaging of labeled 
axon terminals of individual neurons. First of all, our preliminary experiments 
suggested that immunostaining of mounted cryosections was less sensitive and less 
specific compared to the staining of vibratome sections in a free-floating manner. The 
second issue is the preservation of the tissue structure at the surface of the thin sections, 
as images with proper SNR can only be collected from within 10 µm distance from the 
coverslip. While cryosections were suitable for population-level observations in parts of 
the samples, reliably finding and imaging labeled axon terminals required a more 
consistent preservation of the tissue. Thirdly, as the photoswitching of the fluorescent 
dyes requires the presence of a special imaging medium, it was necessary to store the 
samples between immunostaining and the actual imaging in a way that allows the 
application of fresh imaging medium. Thus, in order to facilitate the use of STORM for 
quantitative cell-specific studies, we have used free-floating immunostaining protocol 
on vibratome sections cut thinner than usual (to 20 µm thickness). After 
immunostaining, the sections were mounted on the coverglasses and dried, to be 
covered with imaging medium only at the beginning of the imaging session (Barna et al. 
2016). 
To validate this protocol, we have used sections from the hippocampi of WT and 
CB1 KO mice (Zimmer et al. 1999), immunostained against both CB1, and the 
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neuropeptide CCK, which is widely used as a marker of CB1-expressing interneurons 
(Katona et al. 1999; Tsou et al. 1999). In the pyramidal layer of the CA1 subfield, we 
have observed the characteristic staining pattern of CB1, labeling varicosities in basket-
like arrays around the immunonegative somata of pyramidal neurons (Figure 6a). These 
varicosities presumably correspond to inhibitory axon terminals of GABAergic 
interneurons, as indicated by CCK-immunoreactivity (Figure 6b). STORM images of 
the axon terminals revealed hollow, ring-shaped CB1 labeling, with a level of detail 
significantly exceeding that of the epifluorescent images (Figure 6c-f). This striking 
sub-boutonal staining pattern is likely to result from the predominant plasma membrane 
targeting of the receptors, which has been reported previously by electron microscopic 
studies (Katona et al. 1999; Nyiri et al. 2005). As the focal depth of a single STORM 
image is maximum 600 nm with the sensitivity of detection sharply decreasing away 
from the focal plane, while the diameters of the axon terminals range from 800 to 1000 
nm (Takács et al. 2014), these STORM images represent partial optical sections of the 
boutons.  
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Figure 6. Visualization of CB1 receptors on hippocampal axon terminals using 
STORM. (a) Epifluorescent micrograph of CB1 immunostaining in the pyramidal layer 
of hippocampal CA1 region, illustrating the labeling of varicosities around 
immunonegative somata. (b) The same varicosities are also positive for CCK. (c) 
STORM image of the same field of view reveals the sharp plasma membrane labeling 
visualized by CB1. (d-f) High magnification view of the boxed region from the top 
panels. (g-h) The CB1 STORM signal was nearly undetectable in sections from CB1 KO 
mice. (i) Histogram of the CB1 NLP detected in CCK-positive varicosities in WT and 
KO samples. The low level of background labeling indicates the specificity of the 
antibody and the imaging process (Dudok et al. 2015). 
As the vast majority of CCK-containing cells in the CA1 co-express CB1 receptors 
(Bezaire and Soltesz 2013; Katona et al. 1999; Marsicano and Lutz 1999), we were able 
to evaluate the specificity of the CB1 immunoreactivity selectively in the investigated 
profiles, in CCK-positive varicosities (Figure 6g-h). Quantification of the CB1 STORM 
NLP in rectangular regions of interest (ROIs) selected based on the epifluorescent 
image of CCK labeling revealed less than 1% background in the CB1 immunostaining 
(n = 208 and 200 ROIs from 3 WT and 2 KO mice, respectively). In boutons from WT 
mice, the CB1 NLP was moderately variable (Figure 6i, interquartile range (IQR): 223-
DOI:10.14753/SE.2017.1972
50 
 
358 NLP, CV = 37%). Altogether, these results indicate that similarly to our previous 
observations in cell cultures, CB1 immunostaining detected by STORM is also sensitive 
and specific in fixed hippocampal sections. 
4.2.2. Implementing STORM for studying identified neurons 
While the sampling strategy used in the previous measurements is suitable for 
assessing background labeling, it is not adequate for quantitative characterization of 
CB1-expressing axon terminals, because CCK, being a neuropeptide stored in a few 
dense-core vesicles per axon terminal (Ghijsen et al. 2003), does not outline the area of 
the boutons precisely, and is likely to introduce a sampling bias towards larger boutons 
with higher probability of CCK content. Moreover, multiple subclasses of interneurons 
express CB1 in the CA1 region. While these neurons are clearly segregated into two 
groups based on their preferential targeting of perisomatic or dendritic domains (Cope et 
al. 2002; Klausberger and Somogyi 2008), some studies suggest that both populations 
can be further classified. A subpopulation of perisomatic CCK/CB1-positive cells co-
expresses a vesicular glutamate transporter (Somogyi et al. 2004), and dendritically 
targeting cells may show different pattern of axon arborization, identified as perforant 
path-associated or Schaffer collateral-associated interneurons (Ali and Todorova 2010). 
One study has identified 7 morphological types of CCK-immunoreactive interneurons, 
based on the laminar distribution of their axons (Pawelzik et al. 2002). As it is already 
known that different populations of CCK/CB1-positive interneurons show 
fundamentally different sensitivity to both exogenous and endogenous cannabinoids 
(Lee et al. 2010a), we aimed to develop a cell-specific bouton sampling approach which 
allows the integrated analysis of morphological, physiological and nanoscale molecular 
parameters of neurons. 
To this end, we have carried out patch-clamp electrophysiological recordings in 
acute hippocampal slice preparations, and labeled the recorded cells with the small 
molecule tracer biocytin in the intracellular solution. We have recorded from large 
multipolar neurons located in the stratum radiatum of the CA1, and measured their 
passive and active intrinsic membrane properties and firing patterns in response to sub-
threshold current injections. Most of the cells exhibited low frequency, adapting firing 
behavior, known as the regular spiking firing pattern (Figure 7a,d), which is a 
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characteristic electrophysiological feature of CCK/CB1-expressing interneurons 
(Kawaguchi and Kubota 1998; Lee et al. 2010a; Neu et al. 2007). The slices were fixed 
and the biocytin labeling was developed after the recording, allowing post-hoc 
morphological characterization. The vast majority of cells belonged to either of two 
distinctive morphological types: cells displaying selective targeting of the axons to the 
stratum pyramidale (Figure 7b) were classified as perisomatically targeting (PtIN), 
whereas cells with extensive axonal arborization in strata radiatum and oriens (Figure 
7e) were classified as dendritically targeting interneurons (DtIN).  
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Figure 7. Morphological classification of regular-spiking interneurons. (a) 
Multipolar neurons in the CA1 radiatum were recorded in whole-cell patch-clamp 
configuration. The voltage traces in response to hyperpolarizing and depolarizing 
current steps reveal the regular spiking phenotype characteristic to CCK/CB1-expressing 
interneurons. (b) The cells were filled with biocytin through the patch pipette, 
developed using fluorescent streptavidin conjugates, and imaged using confocal 
microscopy. Reconstruction of a representative perisomatic interneuron depicts the 
concentration of axons in the pyramidal layer. (c) Quantitative evaluation of the 
distribution of axonal varicosities allows the unbiased categorization of the cell as PtIN. 
(d-f) In case of a second cell, the same experimental workflow revealed a similar 
accommodating firing pattern, but remarkably different distribution of the axons. This 
cell was categorized as DtIN (Dudok et al. 2015). 
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Some cells, however, were difficult to subjectively classify into one of these two 
groups. Thus, to avoid the pitfalls of examining heterogeneous cell populations, we 
have developed a quantitative approach for the characterization of axonal morphology, 
the bouton distribution index (BDI). In order to calculate this index, the borders of the 
pyramidal layer, as well as the positions of axonal varicosities (n = 997 ± 58 
varicosities/cell) were marked on the maximum intensity projections of confocal image 
stacks captured from each cell, and the distances of varicosities from layer borders were 
calculated, and normalized to the local thickness of the pyramidal layer. The index was 
then calculated from the descriptive statistics (mode and IQR) of the relative distances 
(see Methods). The value of the index is greater than 1 if the mode of the axon 
distribution is close to the center of the pyramidal layer, and the distance between the 
first and third quartiles (IQR) is less than the thickness of the pyramidal layer. On the 
contrary, the value of the index is less than 0.5 if the mode is outside the pyramidal 
layer and the IQR is greater than the thickness of the pyramidal layer. Thus, the BDI 
was used to separate clearly perisomatically (BDI>1) and dendritically targeting 
(BDI<0.5) neurons. Intermediate cells, accounting for less than 5% of all recorded cells 
with adequate recovery of axons for the BDI analysis, were excluded from the sample.  
After establishing an unbiased method for the morphological classification of the 
cells, we have compared their active and passive electrophysiological properties across 
cell types (n = 14 and 18 perisomatic and dendritic cells, respectively, all of which 
displayed continuous firing during the evaluated depolarizing current injection, Mann-
Whitney U test, Figure 8). Comparison of cell types revealed the lack of significant 
difference in the resting membrane potential, input resistance, relative sag amplitude, 
rebound potential, and action potential amplitude (Figure 8a-e). However, the two 
populations of cells did display some distinctive active physiological properties, as 
perisomatic CB1-positive cells expressed wider action potentials, smaller 
afterhyperpolarization, and slower initial firing, resulting in a lesser degree of frequency 
adaptation compared to dendritic cells (Figure 8f-h). These results suggest that while 
perisomatically and dendritically targeting regular spiking interneurons share a similar 
electrophysiological phenotype, cell type-specific differences are indeed present 
between the two groups, confirming the existence of multiple distinct subpopulations 
within CCK/CB1-expressing interneurons. 
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Figure 8. Electrophysiological properties of regular spiking perisomatically- 
and dendritically-targeting interneurons. Comparison of morphologically identified 
cells, graphs show raw data (individual cells) and median ± IQR (Dudok et al. 2015). 
After the detailed morphological and electrophysiological characterization of the 
recorded cells, we aimed to obtain high resolution molecular localization data from the 
axon terminals of the identified neurons. To this end, we have embedded the 300 µm-
thick slices containing the developed neurons in agarose, and cut the blocks to 20 µm-
thin sections on a vibratome. Then, we have performed immunostaining optimized for 
STORM as shown earlier (Figure 6). The imaging approach used before, however, was 
not suitable for precisely outlining the area of the filled axon terminals, due to the low 
spatial resolution of epifluorescence images obtained on the EMCCD camera. As the 
EMCCD is optimized for sensitivity to be able to detect single-fluorophore blinking 
events, the relatively large physical pixel size of the sensor results in the undersampling 
of the image (160 nm/px using 100x objective). Moreover, the epifluorescent 
configuration introduces severe blurring of the image due to the effects of light 
diffraction and the presence of out-of-focus signal. To improve the resolution, we have 
equipped the STORM microscope with a confocal scan head, and used confocal 
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imaging followed by deconvolution (see Figure 9). Deconvolution is a post-acquisition 
computational method, which, using the a priori knowledge of the shape of the PSF 
calculated from the optical parameters of the imaging, can enhance the resolution of 
light microscopy images, and remove noise and off-focus signal (Landmann 2002). 
 
Figure 9. The effect of deconvolution on confocal image stacks. Maximum 
intensity projection of the same confocal image of CB1 immunostained fibers in the 
pyramidal layer of CA1 before (a) and after deconvolution (b). The improved resolution 
of the deconvolved image is noticeable on the preterminal axonal segments and on the 
well-resolved doughnut-shaped organization of CB1 on axon terminals. 
On the combined confocal-STORM platform, we have localized the labeled axonal 
varicosities of the filled interneurons, and captured confocal image stacks of the 
biocytin fluorescence, followed by 3D-STORM imaging of anti-CB1 immunostaining 
(Figure 10). After alignment of the respective image pairs (see Methods), it became 
possible to dissect the STORM LPs belonging to a given axon terminal. Throughout the 
study, we have used this correlative imaging approach to obtain nanoscale molecular 
distribution data from the axon terminals of identified interneurons. 
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Figure 10. Correlated confocal and STORM imaging from axon terminals of 
individually labeled neurons. (a) Deconvolved confocal image of a biocytin-labeled 
string of boutons from an identified, morphologically and electrophysiologically 
characterized interneuron. (b) Overlaying the STORM image reveals dense CB1 
immunolabeling on the surface of axon terminals and on connecting axonal segments. 
Maximal intensity projection of 3 neighboring confocal sections (150 nm step size) is 
shown, to match the volume of the STORM image. The same approach is used 
throughout the study when correlated confocal and STORM images are shown. (c) 
STORM image of the boxed axon terminal illustrates the doughnut-shaped distribution 
of CB1 on the optical section of the bouton, presumably resulting from the preferential 
plasma membrane targeting of the receptor.  
4.3. Distribution of CB1 on axon terminals of perisomatically and dendritically 
targeting interneurons 
4.3.1. The abundance of CB1 on GABAergic axon terminals 
Could the higher cannabinoid sensitivity of PtINs be simply explained by more CB1 
receptors on their axon terminals? To test this hypothesis, we have first measured the 
CB1 content of on average 50 ± 3 axon terminals from 6 perisomatic and 6 dendritic 
interneurons with correlated confocal and STORM microscopy. From the confocal 
images of the biocytin cell fill, we have also determined the size and morphological 
descriptors of the axon terminals. Comparing the circularity, aspect ratio, and solidity of 
the axon terminals revealed no significant difference between perisomatic and dendritic 
cells (n = 6-6 cells, p > 0.05, Mann-Whitney U test, Figure 11), even though these cell 
types target different subcellular domains of the postsynaptic pyramidal neurons.  
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Figure 11. Morphological analysis of axon terminals of perisomatically and 
dendritically targeting interneurons. Shape descriptors (dimensionless numbers) were 
measured on confocal images of biocytin-labeled axon terminals using ImageJ. 
Differences were not significant between cell types (p > 0.05). Graphs show raw data 
(mean values of cells), and median ± IQR (Dudok et al. 2015).  
However, when we determined the size of the axon terminals (measured as either 
the 2D area of the freehand shape drawn on the deconvolved confocal image of the axon 
terminal, or as the perimeter of a 2D convex hull fitted on the CB1 LPs), we have found 
that perisomatic cells had 39% larger axon terminals compared to dendritic interneurons 
(n = 6-6 cells, Mann-Whitney U test, Figure 12a-b). The abundance of CB1 receptors, 
assessed by counting the NLP in the CB1 STORM image under the 2D area selected 
based on the biocytin confocal image, was also 40% higher on the axon terminals of 
PtINs (Figure 12c). 
Does the similar effect size in the cell type-specific differences in bouton size and 
CB1 NLP reflect correlation between the two parameters? To address this question, we 
have compared these on the level of individual axon terminals. As the downstream 
signaling of CB1 occurs in the plasma membrane (Wilson et al. 2001), the most 
meaningful way to express correlation is to compare the surface area of the membrane 
to the number of receptors. However, the exact measurement of the membrane surface 
from which the STORM LPs are collected is not feasible, because the non-uniform 
detection sensitivity across the axial dimension (see Figure 4). Thus, we have used the 
2D perimeter of the axon terminals, which is proportional to the membrane surface in 
the optical cross-section of the axon terminal. Despite the relatively high variability in 
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CB1 NLP (CV = 56%), CB1 levels expressed a moderately strong correlation with 
perimeter in the boutons of both perisomatic and dendritic interneurons (n = 279 and 
334 terminals, respectively, Spearman’s rank order correlation, Figure 12d).  
 
Figure 12. The CB1 content scales with the size of inhibitory axon terminals. (a-
b) Axon terminals of PtINs are larger than those of DtINs. (c) In parallel, perisomatic 
boutons contain more CB1 receptors. (d) CB1 NLP is correlated with bouton size at the 
level of individual axon terminals. (e-f) On average, perisomatic and dendritic 
interneurons contain similar density of presynaptic CB1 receptors. Graphs show raw 
data (mean values of cells), and median ± IQR (Dudok et al. 2015).  
In the light of the correlation between the abundance of CB1 and the size of axon 
terminals, we asked whether the density of CB1 is constant across boutons, or between 
cell types. While we still have found substantial variability on the level of individual 
terminals (CV = 41%), no significant difference was present between the mean values 
of PtINs and DtINs (Figure 12e-f). Taken together, bouton size is a major predictor of 
the number of CB1 receptors, and while additional factors may contribute to the 
variability between axon terminals, both investigated interneuron subclasses express 
presynaptic CB1 in a similar density. 
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4.3.2. Validation of the CB1 density measurements 
Although we have shown in cell cultures that the STORM NLP in anti-CB1 
immunostaining is a reliable reporter of CB1 protein abundance (see Figure 3), it cannot 
be ruled out that the similar apparent endogenous CB1 density on the surface of different 
types of interneurons is the consequence of saturation effects. Thus, we have directly 
tested whether the measured density values are in the dynamic range of detection. First, 
we have compared the STORM labeling density in ROIs (one for every bouton, 30 by 
30 confocal pixels each, area = 0.0064 µm2) placed on axon terminals with ROIs of the 
same size on the plasma membrane of EGFP-CB1 expressing HEK cells (n = 10 ROI 
per cell). 
Notably, the axon terminals of both cell types exhibited CB1 density values (median 
= 2095 NLP/µm2) within the range between the two extreme HEK cells (medians = 824 
to 4680 NLP/µm2) (Figure 13a). In agreement with the previous results from all axon 
terminals (see Figure 12e-f), the mean density of CB1 in the ROIs on boutons of 
perisomatic and dendritic interneurons was similar (n = 6-6 cells, Mann-Whitney U test, 
p = 0.59). Next, we have determined the range of labeling densities on boutons by 
averaging the ROIs from each individual interneuron, and calculating the mean ± SD 
ranges of the cell mean values. Interneurons exhibited moderate variability in the mean 
CB1 density of their axon terminals, as 10 of the 12 interneurons had mean values 
within the aforementioned range. Then, HEK cells with their mean values within the 
density range of interneuron axon terminals were selected (n = 20 HEK cells). The 
correlation between intrinsic EGFP fluorescence intensity and CB1 STORM NLP (see 
Figure 3c) was remarkably strong and highly linear within this range (Spearman’s rank 
order correlation, Figure 13b) in this subset of HEK cells covering the STORM LP 
density range of endogenous CB1 on interneuron axon terminals, indicating that the 
immunostaining and imaging protocol is not saturated. Moreover, examining the 
histogram of local STORM signal densities expressed as the number of neighboring 
points within 50 nm 3D Euclidean distance from each CB1 LP on axon terminals 
revealed right-tailed distribution (Figure 13c), which also argues against the possibility 
that detection is saturated at a high fraction of the LPs. 
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Figure 13. The density of CB1 LPs on axon terminals is in the dynamic range of 
the measurement. (a) The density of CB1 STORM signal is within the range defined by 
the two HEK cells with the lowest and highest expression levels of EGFP-CB1. The 
graph shows raw data (ROIs), and median ± IQR. (b) The correlation between EGFP 
fluorescence intensity and anti-CB1 STORM NLP in individual HEK cells is highly 
linear within the population of transfected HEK cells within the STORM density range 
defined as the mean ± SD of the mean endogenous CB1 STORM density on 
interneurons. (c) Histogram of local STORM signal densities in spheres of 50 nm radius 
around each LP of the CB1 STORM images of axon terminals. (d) The perimeter of a 
2D convex hull fitted on the CB1 STORM LPs of each axon terminal was calculated 
using LPs from the first n imaging cycles. Mean ± 95% confidence interval of the mean 
of 6 dendritic interneurons (normalized to the mean of perisomatic cells) is shown as a 
function of n. (e) The same approach was used to show the difference in CB1 NLP 
between cell types. (f) The CV (%) of nearest neighbor distances within the CB1 LPs 
detected in the first n cycles on each bouton (median ± IQR) is shown as the function of 
n. The high initial variance (note the logarithmic scale) which is later reduced and 
constant reflects undersampling of the receptors only in the first 400 cycles (Dudok et 
al. 2015). 
Finally, we have tested whether the number of camera frames captured for the 
reconstruction of each STORM image is sufficient to reliably determine the density of 
presynaptic CB1 receptors on axon terminals. Figure 13d-e show the difference in 
bouton perimeter and CB1 NLP between the two interneuron subtypes, calculated from 
the LPs detected during the first n cycles of  imaging. In both cases, the cell type-
specific differences shown earlier (Figure 12b-c) were statistically significant already 
after a few 100s of cycles, and remained highly constant at late phases of the imaging, 
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indicating that the conclusion of the experiment is independent of the length of imaging. 
The images were also suitable to probe nanoscale CB1 distribution, as the CV of nearest 
neighbor distances between LPs was constant after the initial phase of imaging (Figure 
13f). These results indicate that the imaging parameters used throughout the study allow 
detecting a sufficiently large fraction of endogenous CB1 without saturation, enabling 
the quantitative investigation of nanoscale molecular distribution. 
4.3.3. Nanoscale distribution of CB1 on the membrane of GABAergic axon 
terminals 
The similar density of CB1 receptors on the boutons of both PtINs and DtINs is in 
apparent contradiction to the higher efficacy of cannabinoids on perisomatic inhibition, 
suggesting that the abundance of presynaptic CB1 receptors per se is not the main factor 
setting the cannabinoid sensitivity of synapses. Indeed, while glutamatergic synapses 
contain considerably lower level of CB1 receptors compared to GABAergic synapses 
(Katona et al. 2006; Marsicano and Lutz 1999), behavioral effects of cannabinoid 
administration are mostly mediated by CB1 receptors on glutamatergic axon terminals 
(Monory et al. 2007), and the G-protein mediated signaling downstream to CB1 is also 
higher in excitatory cell types (Steindel et al. 2013). Can a different efficacy of CB1 also 
explain the subtype-specific differences in cannabinoid signaling between GABAergic 
interneurons?  
To date, we are not aware of any studies revealing details on the specific 
pharmacology and G-protein coupled signaling of CB1 on perisomatic and dendritic 
inhibitory synapses. On the other hand, the nanoscale distribution of CB1 in relation to 
active zones could also contribute to increased cannabinoid sensitivity of perisomatic 
interneuron synapses. Regulation of synaptic transmission by CB1 occurs through the 
plasma membrane-delimited inhibition of VGCCs (Herlitze et al. 1996; Wilson and 
Nicoll 2001), and it is likely that only calcium channels in the vicinity of the calcium 
sensors can trigger vesicle release (Chen et al. 2015; Eggermann et al. 2012). Thus, the 
domain within which the activation of CB1 can affect neurotransmitter release may be 
limited to the vicinity of VGCCs coupled to the release sites. The reported diffusion 
coefficients for GPCRs in plasma membranes is typically in the 10
-9
 cm
2
/s range, 
regardless of native, oligomerized, or ligand-bound states (Herrick-Davis et al. 2013). 
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Based on single-particle-tracking of GPCRs and these diffusion coefficients, the 
estimated domain size of a GPCR signaling unit is about 150-200 nm (Daumas et al. 
2003). Indeed, previously it has been suggested that CB1 is enriched in a perisynaptic 
annulus at GABAergic axon terminals (Nyiri et al. 2005). Thus, we have aimed to 
investigate the nanodomain-specific abundance of CB1 at synapses of perisomatically- 
and dendritically targeting terminals. 
 In contrast to electron microscopy, STORM does not allow the direct visualization 
of synapses. Thus, to study the synapse-related nanoscale distribution of CB1, we have 
utilized immunostaining to label synaptic active zones. The presynaptic active zone 
protein bassoon is involved in the targeting of VGCCs to the synaptic active zone in 
various synapses (Frank et al. 2010; Nishimune et al. 2012; Richter et al. 1999; tom 
Dieck et al. 1998). Moreover, bassoon co-immunoprecipitates with VGCCs, and its 
molecular abundance is correlated to the quantity of calcium channels in synaptosomes 
(Carlson et al. 2010; Wilhelm et al. 2014). First, we have tested whether bassoon 
immunolabeling can visualize GABAergic synapses in our model system (Figure 14). 
We have filled pyramidal neurons during patch-clamp recordings, and immunostained 
the sections containing filled cells against CB1 and bassoon, using secondary antibodies 
conjugated with activator-reporter dye pairs. Confocal microscopy revealed CB1-
expressing varicosities impinging on the somata (Figure 14a-b) and dendrites (Figure 
14d-e) of pyramidal cells. The appositions between the varicosities and the postsynaptic 
cell are putatively GABAergic synapses. Indeed, on dual-channel STORM images, 
clusters of bassoon labeling were visualized inside the CB1-positive varicosities, exactly 
at the contact sites with the biocytin-labeled profiles (Figure 14c,f). Together with the 
immunogold electron microscopy evidence for the targeting of bassoon to presynaptic 
active zones, this striking specificity of bassoon STORM labeling to contact sites 
enabled us to use bassoon as a synaptic marker in the forthcoming experiments (Richter 
et al. 1999). While the dual-channel STORM imaging approach allows the precise 
labeling of the position of synaptic active zones together with the measurement of 
extrasynaptic CB1 LP numbers and positions on the same axon terminal, it is important 
to note that crosstalk between channels and the applied crosstalk subtraction algorithm 
makes quantification unreliable in areas where signals from both channels may overlap, 
i.e. inside synaptic active zones. 
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Figure 14. Bassoon STORM labeling labels synapses in CB1-expressing axon 
terminals. (a) Confocal image of the cell body of a filled CA1 pyramidal cell and 
adjacent CB1-expressing varicosities. (b) Enlarged view of the boxed region illustrates 
the close contact between the axon terminal and the postsynaptic cell. (c) Dual-channel 
STORM image of CB1 and bassoon immunolabeling reveals the specific accumulation 
of bassoon STORM signal to the contact site, consistent with labeling of the presynaptic 
active zone. (d-f) The same approach shows the presence of bassoon at contact sites of 
dendritically-targeting varicosities. The experiment was replicated in 10 cells from one 
mouse (Dudok et al. 2015). 
Next, we have carried out the same dual-channel STORM experiment on slices 
containing filled PtINs and DtINs. On the biocytin-labeled axon terminals of 
electrophysiologically and morphologically characterized interneurons, bassoon 
immunostaining revealed clusters (Figure 15a-d), similarly to the results shown 
previously on the inputs of filled pyramidal cells. To test whether there are major cell 
type-specific differences in the nanoscale distribution of CB1 in relation to the bassoon 
clusters, first we have measured the 3D Euclidean distance of each CB1 LP from the 
nearest bassoon LP (Figure 15e,g). On average, the CB1-to-bassoon distances were 
similar in the axon terminals of PtINs and DtINs (Figure 15i, n = 311 and 141 axon 
terminals from 10 perisomatic and 10 dendritic cells, Mann-Whitney U test, p = 0.69). 
However, as CB1R downstream signaling is confined to the membrane, Euclidean 
calculations underestimate the actual CB1-bassoon distance along the plasma membrane 
of the axon terminal. As this effect depends on the size of the bouton, and the two cell 
types are different in bouton size (see Figure 12a-b), we sought for a more direct 
measure for evaluating the nanodomain-specific distribution of CB1. Exploiting the fact 
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that CB1 itself decorates the plasma membrane of axon terminals at high density, the 
bounding volume of the boutons can be approximated by fitting a convex hull on the 
CB1 LPs. Because the convex hull operation discards LPs inside the volume, and only 
the LPs belonging to the axon terminal are selected (based on the biocytin labeling), the 
surface of this convex hull can be considered as an estimation of the plasma membrane. 
Indeed, the majority of CB1 was found close to the convex hull (79 ± 1% and 81 ± 1% 
of LPs within 200 nm 3D distance from the convex hull surface, n = 280 and 141 
perisomatic and dendritic axon terminals, respectively).  
To obtain more relevant data on CB1-bassoon distance, we have measured the 
length of the shortest path between LPs on the surface of the convex hull fitted on the 
CB1 channel. However, in agreement with the Euclidean distance measurements, the 
mean surface distance of CB1 LPs from bassoon LPs was similar between cell types 
(Figure 15i, n = 33 and 22 axon terminals from 8 perisomatic and 5 dendritic cells, 
Mann-Whitney U  test, p = 0.31). Note, that while both the Euclidean and surface 
distances were measured from data from the same experiment, the number of analyzed 
boutons is lower for surface distances, as due to computational limitations, only axon 
terminals with simple convex morphology and a single bassoon cluster were included. 
Importantly, as the STORM image represents an optical section of the axon terminal, 
not all faces of the convex hulls represent actual surface areas of the bouton, and thus, 
measurements obtained with this method are approximative. Axon terminals with large 
convex hull faces representing false surfaces were discarded from the analysis. 
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Figure 15. Homogenous distribution of CB1 on the surface of axon terminals. 
(a-b) Perisomatic interneurons were filled with biocytin, immunostained against CB1 
and bassoon, and imaged using dual-channel STORM. While CB1 labeling decorated 
the entire surface of the bouton, bassoon labeling was restricted to clusters at the edge of 
axon terminals. (c-d) The same approach was used to label axon terminals of DtINs. (e-
h) Three-dimensional renderings of the optical sections of two axon terminals showing 
the CB1 and bassoon LPs, together with the trajectories used for distance measurements 
(yellow), and the convex hull fitted on the CB1 points (silver). (i) The mean distance of 
CB1 from bassoon was similar between axon terminals of PtINs and DtINs, measured 
either as Euclidean or surface distance. The graph shows raw data (boutons) and median 
± IQR. (j) The spatial density of CB1 LPs, measured at random points of the surface of 
the convex hull (median ± IQR), was similar between cell types, and was independent 
of the distance from bassoon-labeled active zones (Dudok et al., 2015). 
To determine if CB1 is specifically enriched in the proximity of synaptic active 
zones, we sought to directly measure the density of LPs on the surface defined by the 
convex hulls. Measurement points were placed at random positions on each triangular 
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face of the convex hull at a high density to uniformly cover the entire surface. Then, the 
number of CB1 LPs within a given distance (200 nm, which is larger than the separation 
between measurement points) was determined for each point, together with the surface 
distance of the given point from the nearest bassoon LP. Thus, by pooling measurement 
points into bins, we could estimate the average density of CB1 at the surface of the 
convex hulls (representing optical sections of the axon terminals) at certain distances 
from active zones (Figure 15j). Contrary to our expectations, we have found that the 
surface density of CB1 near synaptic active zones was identical between PtINs and 
DtINs (n = 33 and 22, respectively, p = 0.86, Mann-Whitney U test). Contradicting 
earlier reports (Nyiri et al. 2005), the density of receptors near synapses was not higher 
than at more distant membrane parts of boutons (p = 0.64 and 0.28 for perisomatic and 
dendritic cells, respectively). This contradiction might be the consequence of the 
interfering effects of bassoon signal at active zones, thus, the measurement of CB1 
density is not reliable inside or in the immediate vicinity of bassoon clusters. 
Altogether, these data suggest that CB1 receptors cover the extrasynaptic membrane of 
GABAergic interneuron axon terminals homogenously, with similar density between 
subtypes of CB1-positive interneurons. Therefore, the number and nanodomain-specific 
positioning of receptors is not likely to be under precise regulation, and is not likely to 
underlie cell type-specific alterations in the cannabinoid sensitivity of synaptic 
transmission. 
4.4. Organization of presynaptic active zones in CB1-positive axon terminals 
4.4.1. Nanoscale distribution of bassoon STORM labeling 
The endocannabinoid system regulates GABA release by inhibiting the function of 
presynaptic molecules that promote vesicle fusion, such as VGCCs and active zone 
proteins like RIM1α (Chevaleyre et al. 2007; Szabó et al. 2014). The degree of overall 
inhibition should depend not only on the number of activated receptors, but also on the 
number of effector molecules to be controlled by those receptors. The observation that 
CB1 receptor densities are uniform between cell types lead us to hypothesize that a 
difference in the ratio of receptor and effector molecules can underlie the difference in 
cannabinoid sensitivity. But how to measure the number of relevant effector molecules 
to be controlled by CB1? The contribution of different downstream pathways to short- 
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or long-term, tonic or phasic forms of synaptic plasticity in specific types of synapses is 
partially understood (see 1.1.3). However, as shown in glutamatergic synapses, the size 
of presynaptic active zones correlates tightly with release probability, the amplitude of 
calcium transients, and also with the abundance of VGCCs and RIM proteins (Holderith 
et al. 2012). Thus, active zone size can serve as a proxy to measure the potency of the 
axon terminal for vesicle release. As bassoon expression selectively labels presynaptic 
active zones, we have performed single-channel STORM imaging of bassoon in labeled 
axon terminals of identified interneurons (Dani et al. 2010; Richter et al. 1999; tom 
Dieck et al. 1998; Wilhelm et al. 2014).  
Consistently with the active zone-restricted distribution of bassoon, STORM 
images of anti-bassoon immunostaining show the accumulation of bassoon in distinct 
puncta near the edge of the axon terminals (Figure 16). Unlike in the case of dual-
channel STORM, the lack of crosstalk and crosstalk-subtraction allows uncompromised 
quantification of the distribution of bassoon in this experiment. Because of the 
conspicuous accumulation of bassoon in multiple spots, we sought to assess the spatial 
clustering of STORM signal in a quantitative manner. To this end, we have applied 
DBSCAN clustering on the coordinates of bassoon LPs inside each axon terminal (Ester 
et al. 1996). This algorithm identifies clustered points based on local density, without a 
pre-defined number of clusters, while localization points present at low density are 
treated as noise. Typically, multiple clusters were identified on each axon terminal 
(Figure 16c,f), in agreement with electron microscopic evidence showing multiple 
anatomical release sites at boutons of CB1-expressing interneurons in the hippocampus 
(Biró et al. 2006). DBSCAN removed ~20% of LPs as noise. As these points are 
isolated from the clustered labeling, and there is no evidence for bassoon to be present 
and functional outside release sites, we found the exclusion of noise points from the 
analysis justified. To overcome the liability from arbitrarily setting clustering 
parameters, we have replicated the results with a wide range of parameter settings with 
the same conclusions (not shown). 
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Figure 16. Bassoon STORM labeling in identified axon terminals exhibits 
clustered distribution. (a) Confocal image of a biocytin-positive axonal varicosity of a 
CB1-expressing PtIN. (b) STORM image of single-channel bassoon immunostaining in 
the area of the axon terminal (green outline) shows clustered appearance. (c) Three-
dimensional rendering of the bassoon LPs of the same axon terminal after spatial 
clustering with the DBSCAN algorithm. LPs belonging to clusters are color-coded for 
cluster membership, LPs classified as noise are hidden. (d-f) The same strategy revealed 
clusters of bassoon labeling in axon terminals of DtINs (Dudok et al., 2015). 
Despite the larger size of perisomatic axon terminals (see Figure 12), axon 
terminals of both PtINs and DtINs contained similar numbers of bassoon LPs (Figure 
17a, n = 349 and 374 boutons from 10 perisomatic and 12 dendritic cells, respectively, 
Mann-Whitney U test), which is in stark contrast with the difference in CB1 NLPs 
measured in a separate single-staining experiment (Figure 17b, two-sample 
Kolmogorov-Smirnov test). However, after spatial clustering of the bassoon LPs, we 
have detected a higher number of clusters in perisomatic axon terminals (Figure 17c). 
Consequently, the size of individual clusters was smaller, indicating a more fragmented 
nanoscale organization of the presynaptic active zone in perisomatic synapses (Figure 
17d). 
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4.4.2. Cell type-specific alterations in local CB1 receptor to effector ratio 
This observation, together with the previously established homogenous distribution 
of CB1 receptors across the plasma membrane of axon terminals, lead us to hypothesize 
that individual presynaptic active zones of PtINs express an increased local ratio of CB1 
and bassoon LPs. To test this hypothesis, we have returned to the data set obtained from 
dual-channel CB1-bassoon STORM experiments to measure the distance of CB1 LPs 
from active zones. As discussed earlier, the distance within which CB1 can affect 
downstream targets is not precisely known, but can be estimated in the range of 150-200 
nm (see 4.3.3). Thus, if the abundance of bassoon is similar between perisomatic and 
dendritic synapses, but there are more CB1 receptors within the relevant distance from 
bassoon due to the more fragmented distribution of bassoon labeling, the local receptor 
to effector ratio will also be higher. Indeed, we have found that there are up to 50% 
more CB1 LPs within a given distance limit from bassoon at perisomatic synapses 
(Figure 17e, n = 80 randomly selected boutons per cell type, two-sample Kolmogrov-
Smirnov test, see the rationale for the downsampling later). As indicated by the uniform 
magnitude of difference across any distance limit, this difference is unlikely to be the 
consequence of a preferential synapse-associated targeting of CB1, but rather result from 
the fragmented positioning of active zones paired with homogenous CB1 distribution. 
DOI:10.14753/SE.2017.1972
70 
 
 
Figure 17.  Fragmented active zone architecture results in higher CB1 receptor 
to effector ratio in axon terminals of perisomatically targeting interneurons. (a) 
Quantification of single-channel bassoon STORM labeling in biocytin-labeled axon 
terminals of PtINs or DtINs. (b) Cumulative histograms comparing bassoon- and CB1-
content of perisomatic and dendritic axon terminals (recorded in separate single-channel 
STORM experiments, data in right panel is replotted from Figure 12c). (c) Perisomatic 
axon terminals contain more clusters of bassoon STORM labeling. (d) Individual 
clusters in perisomatic axon terminals contain fewer bassoon LPs compared to terminals 
of DtINs. (e) In dual-channel STORM images, the number of CB1 NLP within any 
given distance limit from bassoon is higher in perisomatic axon terminals (log scale, 
median ± IQR, from the same data as Figure 15i, insert shows results for the 100 nm 
distance limit with linear scale). Box plots show raw data (mean values of cells) and 
median ± IQR (Dudok et al., 2015). 
An alternative explanation of the higher number of CB1 within a distance limit from 
bassoon could be the larger size, and the larger CB1 content of perisomatic axon 
terminals. To directly test whether the observed alterations reflect true cell type-specific 
molecular differences, or are just emergent features of larger axon terminals of 
perisomatic interneurons, we have analyzed an identically sized bouton population from 
both cell types. To generate this sample, 80-80 axon terminals of both cell types were 
selected in a manner that guaranteed both random sampling and identical size 
distribution of axon terminals (see Methods). Such a sample was generated from the 
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single-channel CB1 and bassoon STORM experiments, and the dual-channel CB1-
bassoon STORM experiment as well. The n = 80 per group sample size was selected as 
the highest n that could return a subpopulation of virtually identical size distribution of 
axon terminals in both cell types (two-sample Kolmogorov-Smirnov test, Figure 18a). 
To maintain comparable statistical power across tests, the same number (80-80) of axon 
terminals were selected at random, without respect to bouton size, for the analysis 
presented earlier on Figure 17e. 
Comparing the CB1 and bassoon NLPs within identically sized bouton populations 
revealed that consistently with our previous results showing identical CB1 density 
between cell types, axon terminals of both cell types contained the same amount of CB1 
LPs, and the distribution of CB1 NLP between individual axon terminals was identical 
(two-sample Kolmogorov-Smirnov test, Figure 18b). On the contrary, but in agreement 
with previous results showing that larger perisomatic terminals expressed the same 
amount of bassoon as smaller dendritic boutons, axon terminals of DtINs contained 
more bassoon LPs compared to perisomatic boutons of the same size (Figure 18b). 
Further in line with previous observations, the number of bassoon clusters per axon 
terminal was similar between cell types (Figure 18c), resulting in smaller size of 
individual clusters in axon terminals of PtINs (Figure 18d). Are these smaller active 
zones surrounded by the same number of CB1 receptors? As expected, identically sized 
axon terminals with identical number of bassoon clusters and homogenous distribution 
of CB1 resulted in identical number of CB1 LPs within any distance limit from bassoon 
in both cell types (Figure 18e). Altogether, these results confirm the cell type-specific, 
bouton-size independent difference in the nanoscale architecture of bassoon-positive 
active zones, and demonstrate the increased CB1 receptor to bassoon ratio at presynaptic 
active zones of PtINs. 
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Figure 18. Nanoscale active zone architecture is determined by cell type, not by 
axon terminal size. (a) To separate the cell type-specific and bouton size-regulated 
differences between interneurons, subsamples of boutons with identical size distribution 
were generated. (b) In identically sized boutons, DtINs contained more bassoon, but the 
same amount of CB1 LPs compared to perisomatically-targeting cells. (c) The number 
of clusters was similar in identically sized axon terminals of both cell types. (d) 
Individual clusters of bassoon STORM labeling contained fewer LPs in perisomatic 
boutons. (e) The nanoscale anatomical organization of bassoon and CB1 resulted in 
identical number of CB1 LPs within a given distance limit from bassoon in identically 
sized bouton populations. Graph shows median ± IQR (Dudok et al., 2015). 
The integrated analysis of results from single-channel and dual-channel STORM 
experiments revealed that terminals of PtINs, the average cluster comprises fewer 
copies of bassoon compared to DtINs, while it is surrounded by the same density of CB1 
receptors. This configuration leads to an increased (by ~45%) putative ratio of CB1 
receptors and their downstream effectors at perisomatic synapses, which might explain 
the increased sensitivity to endogenous and exogenous cannabinoids of PtIN to 
pyramidal cell connections (Lee et al. 2010a). On the other hand, due to the larger size 
of boutons and the higher number of bassoon clusters within, perisomatic axon 
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terminals can be equally competent to release GABA when free from cannabinoid 
control. 
4.5. Dynamic reorganization of CB1 distribution on agonist application 
4.5.1. Effects of endocannabinoids on CB1 localization 
Thus far, we have determined the principles underlying steady-state distribution of 
CB1 receptors, showing homogenous density of CB1 across the extrasynaptic plasma 
membrane of GABAergic axon terminals. After activation by binding of a ligand, 
GPCR signaling is terminated by targeting the receptors to endocytic domains, leading 
to internalization (Moore et al. 2007). Thus, we have predicted that increased levels of 
endogenous or exogenous cannabinoid agonists may lead to reorganization, potentially 
revealing separate functional and reservoir pools of CB1 on axon terminals. To test this 
hypothesis, we first investigated nanoscale CB1 distribution with the cell-specific 
STORM approach developed earlier, after pharmacologically elevating the levels of 
endocannabinoids in slices. We have focused these experiments on PtINs to avoid 
heterogeneity in sampling, assuming that CB1 internalizations will be governed by 
similar principles as in DtINS, because previous results did not uncover any differences 
in the density or distribution of CB1 between interneuron subtypes. 
Incubation of acute brain slices with 100 nM JZL184 (JZL), a selective inhibitor of 
MGL, or with 1 µM PF3845 (PF), a FAAH inhibitor, doubles the levels of 2-AG and 
anandamide, respectively, by preventing their enzymatic degradation (Lee et al. 2015). 
After preincubation with vehicle (DMSO) or inhibitors for 40 minutes, PtINs were 
patched, filled with biocytin, and processed for CB1 STORM imaging as described 
earlier (Figure 19a). Treatment with JZL or PF did not affect the area of axon terminals 
compared to vehicle-treated slices (n = 3, 3 and 7 cells, respectively, 22±12 boutons per 
cell, Kruskal-Wallis ANOVA and median test, p = 0.0961 and 0.2292 between DMSO-
JZL and DMSO-PF, respectively). Surprisingly, treatment did not affect CB1 NLP on 
the axon terminals (Figure 19b).  
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Figure 19. The membrane expression of CB1 is not affected by increased levels 
of endocannabinoids. (a) Biocytin confocal and CB1 STORM images of optical 
sections from axon terminals of individually filled PtINs from slices acutely treated with 
vehicle or with JZL or PF, inhibitors of endocannabinoid-degrading enzymes to increase 
tissue levels of 2-AG or anandamide, respectively. Surface and internal CB1 LPs were 
identified solely for visualization purposes by setting a threshold for the internalization 
index of individual LPs. The edges of the convex hull fit on the CB1 signal is indicated 
by silver lines. (b) Acute elevation of endocannabinoid levels did not alter CB1 NLP on 
axon terminals. (c) Treatment had no effect on internalization index of CB1 LPs 
(determined from the distance of LPs from the center of mass of the bouton). Mean 
values per cell were normalized to the mean of control cells, ns indicates p > 0.5 
between groups, number of cells are indicated in parentheses, error bars represent SEM 
(Lee et al. 2015).  
The unaltered total number of CB1 receptors on individual axon terminals indicates 
that acute elevation of endocannabinoid levels is not leading to degradation of CB1 
receptors. This can mean that the treatment does not alter steady-state internalization, or 
that receptors are removed from the plasma membrane, but are not degraded or 
transported away from the axon terminal within the time frame of the experiment. To 
differentiate between these two possibilities, we sought to determine the effect of 
treatment on the surface versus internal localization of CB1 receptors. The distance of 
each CB1 LP from the center of mass of all LPs of the axon terminal is sensitive to a 
shift of LPs towards the center of the bouton. However, this distance greatly depends on 
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the size of the given axon terminal. To allow comparison of different axon terminals, we 
have calculated an internalization index (distance of LPs from the center of mass over 
the radius of the bouton determined from the confocal image), the value of which would 
approach 0 if all LPs are in the center of the bouton, and approach 1 if all LPs are on the 
surface. After treatment with JZL or PF, the mean internalization index of boutons was 
not changed (Figure 19c), thus, we cannot detect an increase in the endocytosis of CB1 
upon acutely increased levels of endocannabinoids in the tissue. 
4.5.2. Effect of exogenous THC on CB1 localization 
The results showing no reorganization of CB1 receptors upon MGL inhibition are 
surprising, because chronic MGL blockade has been shown to inhibit CB1–mediated 
LTD of GABAergic synapses (Schlosburg et al. 2010). One possible explanation for 
this contradiction is that the duration of preincubation with drugs in the previous 
experiment is too short compared to the time scale of the dynamics of surface CB1 
density. To robustly test the long-term changes in presynaptic CB1 expression at 
GABAergic axon terminals, we have turned to an in vivo animal model. Repeated 
exposure to the phytocannabinoid CB1 agonist THC is also known to induce behavioral 
and functional tolerance for CB1 agonists, while a single injection has no such effect 
(Bass and Martin 2000; Hoffman et al. 2007; Varvel et al. 2005). Thus, we have carried 
out an established chronic THC administration protocol by injecting mice 
intraperitoneally with 10 mg/kg THC twice daily for 6.5 days (Bass and Martin 2000). 
After the last injection, mice were allowed to recover for one additional day, which 
ensures that THC is cleared from the brain, and thus, the chronic effects of THC can be 
studied separately from acute effects (Hoffman et al. 2007). 
To assess the reorganization of presynaptic CB1 receptors at GABAergic axon 
terminals, slices were cut from vehicle- and THC-treated mice, and PtINs were recorded 
and filled. Consistently with the reported loss of CB1 radioligand binding from the 
hippocampus after THC exposure in mice and regular cannabis smoking in humans 
(Hirvonen et al. 2012; Long et al. 2013), levels of CB1 immunostaining were 
dramatically reduced throughout the hippocampus of slices obtained from THC-treated 
compared to control mice (Figure 20). Moreover, and in contrast to the homogenous 
distribution of CB1 on axon terminals in control mice, the extremely weak membrane 
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labeling in THC-treated samples was accompanied by the appearance of punctate 
labeling inside boutons, which might correspond to endocytotic structures. 
 
Figure 20. Reduction in CB1 immunoreactivity in the hippocampus of THC-
treated mice. High-power maximal intensity z-projections of deconvolved confocal 
images from the CA1 pyramidal layer in the hippocampi of control mice and mice 
treated with chronic THC injections. Note the smooth, plasma membrane-like labeling 
on putative GABAergic axon terminals in control sections, which is greatly reduced in 
intensity, and replaced by a more punctate pattern in THC-treated samples. 
Representative images were recorded and modified identically. 
To allow reliable quantitative imaging of CB1 distribution in THC-treated samples, 
we have used a novel CB1 antibody with superior sensitivity for immunostaining 
samples containing filled interneurons for cell-specific STORM (Dudok et al. 2015). On 
the axon terminals of PtINs, CB1 STORM LPs covered the surface in high density 
(Figure 21a-b), as illustrated by 3-dimensional rendering of LPs and the convex hull fit 
on them (Figure 21c). Strikingly, in cells filled in slices from THC-treated mice one day 
after the last injection, the CB1 STORM signal no longer outlined the biocytin-
containing axon terminals clearly (Figure 21d-e). However, the low density of CB1 LPs 
still detected on the surface was adequate to fit convex hulls which faithfully 
represented the shape of the axon terminals (Figure 21f), indicating that CB1 receptors 
were not completely removed from the plasma membrane. In addition to the low-
density surface labeling, clusters of LPs were observed inside the convex hulls, unlike 
in cells from vehicle-treated mice. 
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Figure 21. Chronic THC treatment leads to remodeling of CB1 distribution. (a) 
Confocal image of an optical section from an axon terminal of an identified PtIN filled 
in a section from vehicle-treated mouse. (b) Correlated CB1 STORM image shows that 
CB1 LPs outline the labeled axon terminal. (c) Three-dimensional rendering of CB1 LPs 
belonging to the labeled bouton and the convex hull fit on the LPs. CB1 decorates the 
surface of the axon terminal. (d-f) The same approach was used to evaluate CB1 
STORM signal after chronic THC pre-treatment. The amount of CB1 labeling is 
markedly reduced, and clusters of LPs are detected inside the axon terminals (Dudok et 
al. 2015). 
To quantitatively evaluate the redistribution of labeling, we have measured the NLP 
and the internalization index of PtIN axon terminals (n = 185 and 117 axon terminals 
from 3 vehicle- and 2 THC-treated mice, Mann-Whitney U test). The amount of CB1 
labeling per bouton has decreased significantly by 74% after THC treatment (Figure 
22a), and this change was accompanied by a significant shift of the remaining LPs from 
the surface towards the center of the axon terminals (Figure 22b). Together, these 
results show that chronic treatment with a high dose of THC induces significant 
reorganization of CB1 receptors at GABAergic synapses. 
Next, we have asked the question whether THC-induced reorganization of CB1 is 
reversible. During recovery from THC tolerance, different aspects of cannabinoid 
tolerance are restored with different time courses. For instance, tolerance for THC-
induced hypoactivity is completely restored after 7.5 days, tolerance for antinociception 
after 11.5 days, impairment of LTP after 14 days, and reduction in brain CB1 receptors 
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in human chronic cannabis smokers is restored after 4 weeks of abstinence (Bass and 
Martin 2000; Hirvonen et al. 2012; Hoffman et al. 2007). Thus, to examine the 
correlation between behavioral tolerance and molecular reorganization, we have studied 
recovery after 11.5 days, when the behavioral tolerance (in the tetrade essay) induced by 
the chronic THC treatment regime we have applied is completely restored, and, as a 
positive control for recovery, after 6 weeks, when all reports show complete restoration 
of the endocannabinoid system. After 6.5 days of THC injections as described above, 
mice were allowed to recover, and PtINs were filled to perform cell-specific STORM 
imaging of CB1 immunostaining. After 11.5 days of recovery, the CB1 NLP in THC-
treated mice was still by 35% below the levels measured in the respective controls, 
treated and housed together during the full duration of the experiment (Figure 22a, n = 
283 and 113 boutons from 3 vehicle- and 3 THC-injected mice, respectively, Mann-
Whitney U test). Increased internalization of CB1, however, was no longer evident, as 
the internalization index was similar in both groups (Figure 22b). After the longer 
recovery period of 6 weeks, both CB1 NLP and the internalization index was 
undistinguishable between treatment groups (Figure 22, n = 113 and 92 boutons from 2 
vehicle- and 3 THC-injected mice, Mann-Whitney U test). 
 
Figure 22. Recovery and dose-dependence of molecular reorganization after 
chronic THC exposure. (a) The NLP on axon terminals of individually labeled PtINs 
was determined after THC treatment in four separate experiments, each including 
vehicle-treated mice for designated controls. Chronic THC injections resulted in a 
marked loss of CB1 from axon terminals, which effect recovered only partially within 
11.5 days, and completely within 6 weeks. A lower, therapeutically relevant dosing 
resulted in a lesser degree of reduction in CB1 NLP. (b) The CB1 internalization index 
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was measured on the same axon terminals. Internalization of CB1 was evident only after 
high dose THC treatment, and recovered quickly (Dudok et al. 2015).  
The 10 mg/kg dose of THC used in the above experiments is considered high, as it 
has been established for the purpose of inducing tolerance (Abood et al. 1993; Bass and 
Martin 2000; Oviedo et al. 1993). In humans, peak serum THC levels are approximately 
100 ng/ml at 3 hours after smoking cannabis (Heishman et al. 1990; Huestis 2007). In 
the therapeutic dosing of THC, for instance in the case of Sativex, a combined THC and 
CBD preparation with indication for multiple sclerosis, a lower serum THC level of 10 
ng/ml is targeted to avoid psychoactive effects and the development of tolerance 
(Karschner et al. 2011; Stott et al. 2013). To test whether the significant rearrangement 
of CB1 distribution after chronic treatment with 10 mg/kg THC is prevented when 
lower, therapeutically relevant doses are administered, we have performed the same 
experiment with 1 mg/kg dosing, which does not lead to behavioral effects in the tetrad 
assay (El-Alfy et al. 2010; Varvel et al. 2005). After low-dose treatment, CB1 NLP on 
axon terminals of PtINs decreased slightly, but significantly, by 16%, without any 
noticeable effect on the internalization index (Figure 22, n = 113 and 92 boutons from 2 
vehicle- and 3 THC-injected mice, Mann-Whitney U test). Together, these experiments 
show that chronic effect of exogenous cannabinoid application leads to a dose-
dependent and reversible loss of CB1 from the surface of hippocampal GABAergic axon 
terminals, with different time-scale of receptor internalization and degradation. 
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5. Discussion 
In this study, we have validated the use of immunostaining and STORM for the 
relative quantitative measurement of protein abundance in biological samples at 
nanoscale, and developed a method for the cell-specific analysis of STORM images in 
labeled axon terminals of identified neurons. We have applied this approach to show the 
uniform density of CB1 cannabinoid receptors across the plasma membrane of 
perisomatically- and dendritically-targeting interneurons of the CA1 region of the 
hippocampus. These experiments revealed that the CB1 content is correlated to the size 
of axon terminals, and the boutons of PtINs are larger, and contain proportionally more 
CB1 compared to DtINs. On the contrary, axon terminals of both cell types contained 
equal total amounts of bassoon, which was distributed in more individual clusters in 
PtINs. Synthesizing the results from experiments with single- and double-staining 
against CB1 and bassoon, we have found that identically sized PtIN and DtIN axon 
terminals contain the same number of CB1 to control smaller active zones in PtINs, and 
that in the total population of PtIN and DtIN axon terminals, active zones are controlled 
by more CB1 in PtINs. Consequently, we conclude that the local nanoscale ratio of CB1 
and downstream effectors is considerably higher in PtIN axon terminals. Finally, we 
have shown that chronic application of the exogenous cannabinoid agonist THC, but not 
an acute elevation of the levels of the endocannabinoids anandamide or 2-AG, resulted 
in a reversible, dose-dependent loss of CB1 from the surface of axon terminals. 
Together, these results provide insight into the cell-specific molecular determinants of 
cannabinoid sensitivity, and the molecular background of cannabinoid-induced 
impairment of the control of GABA release at hippocampal inhibitory synapses. 
5.1. Cell-specific STORM enables relative quantitative nanoscale imaging on 
axon terminals of identified neurons. 
Super-resolution fluorescence microscopy has been recently used fruitfully to study 
the nanoscale structure of neurons and protein distribution of synapses. In particular, 
STORM was used to study the axial distance of different pre- and postsynaptic active 
zone and PSD proteins from the cleft, as well as the trans-synaptic alignment of such 
proteins (Dani et al. 2010; Tang et al. 2016). The nanoscale clustering of synaptic 
receptors has also been the subject of extensive research (MacGillavry et al. 2013; Nair 
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et al. 2013). Both STORM and STED were used to map the synaptic inputs of neurons, 
to provide quantitative measures of dendritic spine morphology in the healthy brain and 
in disease, and to uncover unknown structural details of cytoskeletal architecture 
(MacGillavry and Hoogenraad 2015; Sigal et al. 2015; Wijetunge et al. 2014; Xu et al. 
2013). 
Although PALM was used to quantify the number of photoconvertible proteins to 
count genetically labeled postsynaptic scaffolding molecules (gephyrin) at inhibitory 
synapses, to our knowledge, the use of immunostaining and STORM for quantitative 
comparisons has never been evaluated (Maglione and Sigrist 2013; Specht et al. 2013). 
Because of the stochastic nature of STORM, the number of times each fluorophore label 
is detected during the imaging is also probabilistic. Therefore, we aimed to test the 
hypothesis whether the number of localization points (NLP) in a STORM image of a 
region is correlated to the number of target proteins, which is essential for the use of 
STORM to compare protein quantity between samples. Our results obtained from HEK 
cells expressing chimeric CB1 indirectly suggest that the NLP reports protein 
concentration over the density range of CB1 STORM signal on GABAergic axon 
terminals, when imaging conditions are constant across samples. Importantly, with 
SMLM, not only the resolution is improved, but also the sensitivity is increased. 
Contrary to intensity based imaging such as widefield, confocal, STED or SIM 
microscopy, where the SNR is decreased with low density labeling, the SNR for 
detecting an individual blinking event with SMLM is increased with low labeling 
density, due to the decreased background intensity and the constant brightness of 
individual fluorophore images. Therefore, STORM can be especially useful to detect 
low copy number molecules, if a sufficiently sensitive antibody or other labeling 
method is available.   
To study the nanoscale distribution of CB1 receptors on axon terminals, we have 
implemented STORM microscopy in combination with single-cell labeling via patch-
clamp recordings. Using this approach, we were able to measure electrophysiological, 
morphological, and nanoscale molecular features of the same identified neurons. We 
have demonstrated that immunostaining and STORM can be utilized to compare protein 
levels, as the CB1 LP density on axon terminals is above the background and below the 
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saturation levels of the measurement. However, it is important to note that due to the 
reliance of our approach on immunostaining in tissue, it is not known whether epitope 
availability and steric hindrance of antibodies limits the detection of receptors. These 
factors are more likely to confound labeling in the area of the presynaptic active zone, 
where the density of proteins is very high (Wilhelm et al. 2014).  
Correlated light- and electron microscopy has been available for a long time to 
study individually labeled neurons, and, theoretically, can be combined with 
immunogold labeling to solve the problem of imaging nanoscale molecule distribution 
(Gulyás et al. 1993). However, such experiments are extremely time-consuming, and 
therefore, to our knowledge, electron microscopy has not been used in such way. With 
correlated confocal and STORM microscopy, on the other hand, axon terminals of a 
labeled neuron can be imaged in a matter of minutes. Exploiting the performance of 
STORM, we have taken images of over 7000 biocytin-labeled axon terminals of 79 
electrophysiologically and morphologically characterized interneurons, with a 
localization precision of 6 nm in the lateral, and 41 nm in the axial dimensions.  
5.2. Uniform distribution of presynaptic CB1 receptors 
Surprisingly, and in contrast with receptors of anterograde neurotransmitters, CB1 
receptors were distributed uniformly across the plasma membrane of the axon terminals, 
and their numbers were strongly correlated to the size of the bouton (Nair et al. 2013; 
Specht et al. 2013). Importantly, the majority of the receptors were detected on the 
surface of the axon terminal, and only one tenth were detected intracellularly. These 
results, together with the high mobility of CB1 reported in cultured hippocampal 
neurons, and in contrast with a pervious immunogold electron microscopic study, 
suggest the free diffusion of the receptors across the extrasynaptic plasma membrane, 
uncontrolled by anchoring to molecular scaffolds or by endocytosis at steady-state 
(Mikasova et al. 2008; Nyiri et al. 2005). But why are the axons and axon terminals of 
CB1-expressing interneurons covered in CB1 in such high density? Are all receptors on 
the surface contributing to the cannabinoid sensitivity of the synapse? To tackle this 
question, we have examined two subtypes of CB1-expressing hippocampal interneurons 
with markedly different sensitivity to endo- and exogenous cannabinoids, and different 
endocannabinoid tone (Lee et al. 2010a). We have found similar density of receptors on 
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the axon terminals of both cell types, suggesting that receptor density alone does not 
determine the strength of functional CB1-mediated signaling. Supporting this notion, 
calcium imaging experiments found no correlation between the strength of tonic 
endocannabinoid-mediated depression of presynaptic calcium currents and the density 
of receptors on the axon terminal (Lenkey et al. 2015).  
5.3. Implications for the cannabinoid control of synapses 
If CB1 density does not explain the potency of cannabinoid signaling, what other 
factors might be involved? Knockout or mutations of neuroligin 3 or neurexins, 
adhesion molecules that form transsynaptic bridges through the synaptic cleft, caused an 
impairment of tonic endocannabinoid signaling (Anderson et al. 2015; Földy et al. 2013; 
Südhof 2008). Interestingly, CB1-expressing interneurons displayed a remarkably 
selective composition of transsynaptic adhesion molecules and their binding partners 
(Fuccillo et al. 2015). Thus, it is possible that CB1 receptors in the nanodomains of 
vesicle release sites are bound to specific molecules that regulate their function, and that 
only synaptically targeted receptors are competent in regulating release, while 
extrasynaptic receptors may solely serve as a reservoir pool. However, it is currently not 
known whether CB1 is enriched in, or excluded from synapses. Our experiments were 
not optimal for detecting such organizational rules, as the dual-channel STORM 
approach utilized in this study is prone to crosstalk, and high-density bassoon labeling 
of the active zone interferes with the quantitative detection of CB1. Immunogold 
labeling against CB1, using freeze-fractured replica labeling or postembedding 
immunostaining, detected CB1 receptors in the synaptic active zones of interneuron 
axon terminals (Lenkey et al. 2015; Nyiri et al. 2005). These studies, however, did not 
address the question whether the different cannabinoid sensitivity of PtINs and DtINs 
correlates with the density of CB1 in active zones. Therefore, further studies are 
required to identify the pool of CB1 receptors controlling vesicle release. Moreover, 
recent results indicate that different molecular mechanisms might underlie tonic and 
phasic endocannabinoid signaling. Inverse agonists of CB1 were capable of increasing 
the success rate of CB1-expressing GABAergic synapses above baseline levels, 
indicating tonic endocannabinoid signaling, whereas neutral antagonists, despite 
blocking DSI, were ineffective at preventing tonic signaling (Lee et al. 2015). One 
possible explanation for this observation is that ligand-free activity of the CB1 receptor 
DOI:10.14753/SE.2017.1972
84 
 
is responsible for the endocannabinoid tone; however, it is hard to explain the observed 
variability, activity-dependence and synapse-specificity of tonic signaling with bona 
fide constitutive activity (Kim and Alger 2010; Lee et al. 2010a; Neu et al. 2007). 
Moreover, in neuroligin 3 knockout mice, tonic, but not phasic endocannabinoid 
signaling was affected (Földy et al. 2013). Therefore, it is conceivable that transsynaptic 
interactions would regulate tonic signaling by stabilizing CB1 in a constitutively active 
or 2-AG-bound conformation, or trapping constitutively active or 2-AG-bound CB1 in 
the synaptic active zone. It remains to be tested whether phasic and tonic 
endocannabinoid signaling is mediated by the same set of receptors. While tonic 
endocannabinoid signaling appears to be synapse specific, phasic endocannabinoid 
signaling at GABAergic synapses is generally not a homosynaptic mechanism. 
Specifically, i-LTD is proposed to be mediated by 2-AG release from neighboring 
glutamatergic synapses, and DSI can even spread to neighboring non-depolarized cells 
(Chevaleyre and Castillo 2003; Wilson and Nicoll 2001). Thus, it cannot be excluded 
that while synaptic CB1 can mediate tonic, extrasynaptic receptors mediate phasic 
endocannabinoid signaling in interneuron axon terminals. 
5.4. Different presynaptic active zone architecture in perisomatically- and 
dendritically-targeting interneurons 
We have discovered major differences in the nanoscale active zone architecture of 
the two interneuron subtypes. A more fragmented distribution of release machinery 
proteins led to an estimated twofold increase in the local ratio of CB1 receptors over 
their downstream effectors in PtINs, which exhibit strong tonic endocannabinoid 
signaling and high sensitivity to CB1 agonists. Thus, while both CB1 receptors and their 
molecular targets, voltage-gated calcium channels, are mobile at synapses, the relative 
nanodomain concentration of these molecules near vesicle release sites may determine 
the efficiency of cannabinoid-induced synaptic regulation (Mikasova et al. 2008; 
Schneider et al. 2015). The notion that CB1 activation does not inhibit vesicle release in 
an all-or-none, but in a gradual manner, is supported by results showing tremendous 
variability in the baseline failure rate of CB1-positive synapses, as well as by the fact 
that continuous firing of the presynaptic cell can override cannabinoid inhibition (Lee et 
al. 2010a; Losonczy et al. 2004; Neu et al. 2007). 
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Although the interaction between bassoon and VGCCs has been detected 
selectively for the CaV2.1 subtype, this has been studied in cell cultures, or in synapses 
where CaV2.1 is the dominant subtype (Davydova et al. 2014; Frank et al. 2010; 
Nishimune et al. 2012). Thus, it is currently unknown whether bassoon binds CaV2.2 
channels at synapses of CB1-expressing interneurons. It has been suggested that while 
there is precise nanodomain coupling between VGCCs and release sites at synapses 
with CaV2.1, a looser microdomain coupling occurs at synapses with CaV2.2 
(Bucurenciu et al. 2008; Eggermann et al. 2012; Hefft and Jonas 2005). Nevertheless, 
the size of the presynaptic active zone was shown to be tightly correlated with the 
magnitude of calcium transients in the axon terminals of CB1-expressing cells, 
suggesting that components of the active zone tightly regulate calcium signaling even 
with mobile VGCCs (Holderith et al. 2012; Schneider et al. 2015). As the rate of vesicle 
fusion is not a linear function of intra-terminal calcium levels, but scales exponentially, 
it is conceivable that even slight effects on VGCC function can have large functional 
outcome on the amplitude of postsynaptic currents (Szabó et al. 2014).  
5.5. Distinctive features of cannabinoid signaling at GABAergic synapses 
The considerable difference in the CB1 expression level between glutamatergic and 
GABAergic neurons has been noted for a long time (Katona et al. 2006). However, it is 
not understood why excitatory synapses use so much less CB1. In excitatory synapses, 
DSE is less potent than DSI in inhibitory synapses, but, with long depolarization, can 
almost completely block neurotransmitter release (Ohno-Shosaku et al. 2001). In cell 
type-specific knockouts, CB1 on glutamatergic terminals was involved in most of the 
behavioral effects of THC, while the deletion of CB1 from GABAergic terminals left the 
behavioral responses largely unaffected (Monory et al. 2007). Thus, the low amounts of 
CB1 at excitatory synapses result in comparable functional role in controlling 
neurotransmitter release as the strikingly high density at certain GABAergic synapses. 
What molecular differences might explain this discrepancy? It has been shown that the 
downstream G-protein-coupled signaling of CB1 is different in excitatory and inhibitory 
neurons, with increased coupling efficiency at glutamatergic synapses (Steindel et al. 
2013). Moreover, knockout of neurexins resulted in the diminishment of both tonic and 
phasic endocannabinoid signaling at glutamatergic synapses, in contrast with the 
selective effect of neuroligin 3 deletion on tonic signaling at GABAergic synapses 
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(Anderson et al. 2015; Földy et al. 2013). Thus, it is likely that apart from the molecular 
differences in the release machinery, G-protein-mediated signaling, and the type of 
VGCCs, differential nanoscale subsynaptic targeting of CB1, possibly via interactions 
with transsynaptic adhesion proteins, contribute to the high efficiency of CB1 at 
glutamatergic synapses. This hypothesis, and the role of the higher CB1 density at 
GABAergic synapses, remains to be tested. 
5.6. Molecular background of cannabinoid tolerance 
Although the cannabis plant contains more than 60 cannabinoid and more than 100 
terpenoid species that might contribute to the biological effects of marijuana, it has been 
shown that the psychoactive and behavioral (tetrad) effects are mainly mediated by 
THC acting on CB1 (Brenneisen 2007; Huestis et al. 2001; Varvel et al. 2005). The 
chronic exposure to THC leads to impairment of cognitive and memory functions in 
rodents and humans (Bolla et al. 2002; Puighermanal et al. 2009; Volkow et al. 2014), 
the molecular background of which is incompletely understood. Cross-tolerance 
between THC and endocannabinoids is a likely mechanism, as it has been shown that 
chronic THC leads to decreased CB1 levels, and results in impaired endocannabinoid 
signaling (Hirvonen et al. 2012; Hoffman et al. 2003; Suplita et al. 2008). In the 
hippocampus, chronic THC was shown to block LTP induction, which may constitute 
the synaptic background underlying cognitive impairment (Hoffman et al. 2007). 
Interestingly, in this paradigm, GABAergic, but not glutamatergic transmission was 
desensitized to inhibition by CB1 agonists. This role of endocannabinoid-mediated LTD 
of GABAergic synapses as the major expression mechanism of LTP at excitatory 
synapses has been confirmed directly in the potentiation of Schaffer collateral synapses, 
and it is the consequence of the strong contribution of CB1-expressing interneurons to 
feedforward inhibition (Basu et al. 2013). As the knockout of CB1 on GABAergic 
neurons also leads to the abolishment of hippocampal LTP, it is highly likely that 
chronic THC impairs hippocampal synaptic plasticity by the desensitization of 
GABAergic synapses to endocannabinoids (Monory et al. 2015). 
To test this hypothesis, we have studied the effect of a chronic THC treatment 
paradigm which is known to induce behavioral tolerance and reduce synaptic response 
to cannabinoids in mice. Using STORM on identified axon terminals, we have found an 
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estimated 75% reduction in the levels of surface CB1 after treatment with THC. This 
decrease was accompanied by a 50% increased ratio of internalized receptors, 
suggesting that agonist-induced endocytosis in axon terminals followed by degradation 
of internalized receptors leads to the functional blockade of endocannabinoid signaling. 
This reorganization was specific for the chronic application of exogenous cannabinoids, 
as acute increase of endocannabinoid levels did not trigger changes. 
As discussed earlier, the role of the high level of extrasynaptic CB1 receptors on 
GABAergic axon terminals is not understood, and one likely explanation is the function 
of this population of receptors as a reservoir pool to replenish CB1 internalized upon 
agonist binding. Notably, after 11.5 days of recovery from chronic THC, we detected a 
ratio of internalized receptors equal to baseline, while the total number of receptors was 
still 35% lower than in control mice. However, significant although incomplete 
recovery of hippocampal LTP was observed already at 3 days after THC withdrawal 
(Hoffman et al. 2007). This mismatch between the recovery of functional tolerance and 
CB1 levels is consistent with the hypothesis that chronic THC treatment results in the 
depletion of a reservoir pool of CB1 by constantly promoting internalization, and after 
cessation of the treatment, the reservoir pool is filled back relatively slowly by 
constitutive synthesis and axonal transport of CB1. 
However, our findings showing no decrease in CB1 levels upon acute elevation of 
endocannabinoid levels argues against the role of extrasynaptic receptors as a reservoir, 
because it is counterintuitive that such reservoir population of the receptors would prove 
adaptive in any physiological process if doubled 2-AG or anandamide concentrations 
for over an hour did not result in detectable loss of CB1 (Lee et al. 2015). It cannot be 
ruled out though that CB1 distribution in vehicle-treated samples might already reflect a 
reorganized state compared to the in vivo distribution, as endocannabinoid levels were 
constantly increasing in acute slice preparations even without the blockade of 
degradative enzymes. 
In glutamatergic synapses, CB1 levels are considerably lower than in GABAergic 
terminals, however, it has been demonstrated that CB1 on glutamatergic terminals is 
required to mediate some of the behavioral effects of THC in the tetrad assay, while 
none of the effects were altered by the KO of CB1 from GABAergic terminals (Katona 
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et al. 2006; Monory et al. 2007). However, similarly to the recovery of hippocampal 
LTP, tetrad effects were also significantly but partially recovered after already 4.5 days 
of withdrawal, and complete recovery lasted for as long as two weeks. These 
observations suggest that after complete desensitization of synapses with chronic THC, 
it takes similar amount of time for both synapse populations to functionally recover lost 
receptors. To specifically test the existence of a potential reservoir pool of receptor on 
GABAergic, but not on glutamatergic terminals, it would be interesting to see if a less 
potent chronic treatment regime can result in the loss of CB1 sensitivity at 
glutamatergic, but not at GABAergic synapses, and whether a decrease in total CB1 
numbers and increased internalization can be detected before the onset of functional 
tolerance in GABAergic axon terminals. Our experiment with low dose chronic THC 
showed slight decrease in total presynaptic CB1 levels. However, while behavioral 
studies using the same treatment did not detect behavioral tolerance (suggesting lack of 
desensitization of glutamatergic synapses for THC), it is not known if this low dose 
protocol causes impairment of LTP (i.e. desensitization of GABAergic synapses for 
endocannabinoids). 
 Taken together, our results demonstrate the dose-dependent, reversible removal of 
CB1 receptors from hippocampal GABAergic axon terminals during THC tolerance, 
which is likely the molecular background of cannabis-induced cognitive deficits. Using 
lower, therapeutically relevant concentrations did not result in such rearrangement, 
predicting that the use of low doses of cannabinoids does not necessarily lead to 
cognitive side effects. 
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6. Conclusions 
STORM super-resolution microscopy, combined with the labeling of single 
identified neurons during patch-clamp recording, is an efficient approach for the 
correlated analysis of electrophysiological and morphological features of neurons 
together with the underlying molecular properties. The NLP in a STORM image is 
correlated to protein abundance, allowing relative quantitative molecular imaging with a 
resolution rivalling immunogold electron microscopy (6 nm lateral, and 41 nm axial 
localization precision). 
On the axon terminals of CB1-expressing interneurons, size of the terminal is a 
strong predictor of CB1 content, and PtINs have larger axon terminals with 39% more 
CB1 NLP compared to DtINs. The density of CB1 along the extrasynaptic plasma 
membrane is uniform and homogenous in both cell types, therefore CB1 density does 
not explain the greater cannabinoid sensitivity of PtINs. 
The axon terminals of both cell types contain the same levels of bassoon, clustered 
into more, but smaller individual active zones in PtINs compared to DtINs. In PtIN axon 
terminals, 49% more CB1 LPs are found within the active zone nanodomains, which 
might underlie increased cannabinoid sensitivity and tonic endocannabinoid signaling at 
these synapses. 
Acute elevation of endocannabinoid levels by blocking the degradative enzymes of 
anandamide or 2-AG does not result in a change in the CB1 levels of PtIN axon 
terminals, or in the ratio of internalized receptors. Chronic in vivo THC treatment, 
however, induces large, 74% reduction in CB1 NLP on axon terminals of identified 
PtINs, and increased ratio of internalized receptors. Loss of CB1 from the surface of 
interneuron axon terminals is likely the molecular background of THC-induced 
cannabinoid tolerance and cognitive impairments. The chronic reorganization of CB1 
distribution recovered partially (53% of lost signal was restored) after 11.5 days of THC 
withdrawal, and complete recovery was reached after 6 weeks. Chronic treatment with 
low, therapeutically relevant dose of THC induced minor decrease by 16% in 
presynaptic CB1 NLP without detectable change in the ratio of internalized receptors. 
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7. Summary 
Endocannabinoid signaling controls neurotransmitter release throughout the central 
nervous system. Despite the fundamental importance of this phenomenon, the molecular 
principles determining the strength of endocannabinoid-mediated inhibition of synapses 
during physiological and pathophysiological processes is not understood. Studying the 
molecular composition of synapses in a cell type-specific manner has been technically 
challenging. We have developed a method based on patch-clamp recording, anatomical 
reconstruction of individual neurons, immunostaining, and correlated imaging using 
confocal and STORM super-resolution microscopy to reveal cell morphology and 
quantitative molecular distribution, respectively. This approach uniquely enables the 
integrated analysis of electrophysiological, morphological, and nanoscale molecular 
features of individual neurons. 
Cell-specific STORM of the CB1 cannabinoid receptor demonstrated that 
GABAergic axon terminals are decorated with CB1 in a homogenous density. Nanoscale 
cluster analysis of the presynaptic active zone protein bassoon, however, revealed that 
active zones are more fragmented in perisomatically targeting compared to dendritically 
targeting interneurons, giving rise to higher local nanodomain ratios of CB1 and 
downstream effectors. This difference may explain the higher cannabinoid sensitivity of 
the synapses of perisomatically targeting interneurons. Next, we have utilized the cell-
specific STORM approach to study the remodeling of CB1 distribution during a 
pathophysiological process, cannabinoid tolerance. We have found that chronic 
treatment with THC, the main psychoactive compound of cannabis, resulted in 
increased internalization, and decreased quantity of CB1 at axon terminals of 
individually characterized GABAergic interneurons. This reorganization recovered 
surprisingly slowly compared to the restoration behavioral tolerance, and was 
significantly smaller in scale after chronic administration of lower, therapeutically 
relevant and non-psychoactive doses of THC, and undetectable after acutely elevated 
levels of endocannabinoids. These results contribute to the understanding of the 
molecular underpinnings of synaptic cannabinoid signaling and tolerance. 
DOI:10.14753/SE.2017.1972
91 
 
8. Összefoglalás 
Az endokannabinoid jelátvitel a központi szinapszisok széles körében szabályozza 
a neurotranszmitter-felszabadulást. Alapvető jelentősége ellenére az endokannabinoid-
mediált gátlás erősségét meghatározó molekuláris szintű szabályozóelvekről keveset 
tudunk. A szinapszisok molekuláris összetételének sejttípus-specifikus vizsgálatát 
jelentős módszertani korlátok nehezítették. Egyedi idegsejteken végzett patch-clamp 
elvezetés és anatómiai rekonstrukció, valamint immunfestés és korrelált konfokális és 
STORM szuperrezolúciós képalkotás alkalmazásával kifejlesztettünk egy módszert a 
sejtes morfológia és a kvantitatív molekuláris eloszlás együttes vizsgálatára. Ez a 
megközelítés egyedülálló módon lehetővé teszi az egyedi neuronok elektrofiziológiai, 
morfológiai, és nanoskálájú molekuláris jellemzőinek integrált elemzését. 
A CB1 kannabinoid receptor sejt-specifikus STORM vizsgálatával kimutattuk, hogy 
a CB1 homogén sűrűségben fedi a GABAerg axonterminálisok felszínét. A 
preszinaptikus aktív-zóna alkotó bassoon fehérje nanoskálájú klaszter-analízise ezzel 
szemben felfedte, hogy az aktív zónák nagyobb mértékben fragmentáltak 
periszomatikus gátlósejtekben a dendritikus sejtekhez viszonyítva. Ez az elrendezés a 
CB1 és molekuláris effektorainak magasabb lokális arányához vezet, mely különbség 
magyarázhatja a periszomatikus axonterminálisok magasabb kannabinoid-
érzékenységét. Ezt követően a sejt-specifikus STORM módszert alkalmazva 
megvizsgáltuk a CB1 eloszlás átrendeződését kannabinoid tolerancia kialakulása során. 
A kannabisz pszichoaktív hatásáért felelős THC krónikus alkalmazása az egyedileg 
jelölt GABAerg interneuronokon a CB1 receptorok megnövekedett internalizációját, és 
a receptorok számának csökkenését vonta maga után. A bekövetkezett változás csak 
meglepően lassan, a viselkedési hatásban mért toleranciánál is később állt helyre. 
Alacsonyabb dózisú, terápiás alkalmazás szempontjából releváns, és pszichoaktív hatást 
nem kiváltó krónikus THC kezelés hatására a receptorok átrendeződése jóval kisebb 
mértékű volt, az endokannabinoidok szintjének akut megemelésének hatására pedig 
nem volt kimutatható. Ezek az eredmények hozzájárulnak a szinaptikus kannabinoid 
jelátvitel és a kannabinoid tolerancia molekuláris hátterének pontosabb 
megismeréséhez.  
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